BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020;5:428-30. [PMID: 32145190 DOI: 10.1016/S2468-1253(20)30057-1] [Cited by in Crossref: 796] [Cited by in F6Publishing: 541] [Article Influence: 398.0] [Reference Citation Analysis]
Number Citing Articles
1 Syeda S, Baptiste C, Breslin N, Gyamfi-Bannerman C, Miller R. The clinical course of COVID in pregnancy. Semin Perinatol 2020;44:151284. [PMID: 32792262 DOI: 10.1016/j.semperi.2020.151284] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5. [PMID: 32429038 DOI: 10.3390/tropicalmed5020080] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
3 Lodge S, Nitschke P, Kimhofer T, Coudert JD, Begum S, Bong SH, Richards T, Edgar D, Raby E, Spraul M, Schaefer H, Lindon JC, Loo RL, Holmes E, Nicholson JK. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. J Proteome Res 2021;20:1382-96. [PMID: 33426894 DOI: 10.1021/acs.jproteome.0c00876] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Paull JRA, Luscombe CA, Castellarnau A, Heery GP, Bobardt MD, Gallay PA. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses 2021;13:1656. [PMID: 34452519 DOI: 10.3390/v13081656] [Reference Citation Analysis]
5 Gurala D, Al Moussawi H, Philipose J, Abergel JR. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease. Cureus. 2020;12:e10045. [PMID: 32983735 DOI: 10.7759/cureus.10045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Ratemi E, Alghamdi M, Abusnana S, Kashour T, Hamid Q, Halwani R. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. Arch Toxicol. 2020;94:4037-4041. [PMID: 32808185 DOI: 10.1007/s00204-020-02869-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kalkeri R, Goebel S, Sharma GD. SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs. Am J Trop Med Hyg 2020;103:18-21. [PMID: 32406369 DOI: 10.4269/ajtmh.20-0279] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
8 Tecen-Yucel K, Aras-Atik E, Bayraktar-Ekincioglu A. Does therapeutic drug monitoring of hydroxychloroquine improve treatment outcome in intensive care unit patients with COVID-19? Int J Clin Pract 2021;75:e13894. [PMID: 33752299 DOI: 10.1111/ijcp.13894] [Reference Citation Analysis]
9 Verhelst X, Somers N, Geerts A, Degroote H, Van Vlierberghe H. Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium. J Hepatol 2021;74:240-1. [PMID: 32918954 DOI: 10.1016/j.jhep.2020.08.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jiang S, Wang R, Li L, Hong D, Ru R, Rao Y, Miao J, Chen N, Wu X, Ye Z, Hu Y, Xie M, Zuo M, Lu X, Qiu Y, Liang T. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020;7:347. [PMID: 32656222 DOI: 10.3389/fmed.2020.00347] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
12 Knyazev E, Nersisyan S, Tonevitsky A. Endocytosis and Transcytosis of SARS-CoV-2 Across the Intestinal Epithelium and Other Tissue Barriers. Front Immunol 2021;12:636966. [PMID: 34557180 DOI: 10.3389/fimmu.2021.636966] [Reference Citation Analysis]
13 Fathi Karkan S, Maleki Baladi R, Shahgolzari M, Gholizadeh M, Shayegh F, Arashkia A. The evolving direct and indirect platforms for the detection of SARS-CoV-2. J Virol Methods 2022;300:114381. [PMID: 34843826 DOI: 10.1016/j.jviromet.2021.114381] [Reference Citation Analysis]
14 Kimura T, Flynn CT, Whitton JL. Hepatocytes trap and silence coxsackieviruses, protecting against systemic disease in mice. Commun Biol 2020;3:580. [PMID: 33067530 DOI: 10.1038/s42003-020-01303-7] [Reference Citation Analysis]
15 Balaban DV, Baston OM, Jinga M. Abdominal imaging in COVID-19. World J Radiol 2021; 13(7): 227-232 [PMID: 34367509 DOI: 10.4329/wjr.v13.i7.227] [Reference Citation Analysis]
16 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Reference Citation Analysis]
17 Ramos-Lopez O, San-Cristobal R, Martinez-Urbistondo D, Micó V, Colmenarejo G, Villares-Fernandez P, Daimiel L, Martinez JA. Proinflammatory and Hepatic Features Related to Morbidity and Fatal Outcomes in COVID-19 Patients. J Clin Med 2021;10:3112. [PMID: 34300279 DOI: 10.3390/jcm10143112] [Reference Citation Analysis]
18 Xu Y, Barauskas O, Kim C, Babusis D, Murakami E, Kornyeyev D, Lee G, Stepan G, Perron M, Bannister R, Schultz BE, Sakowicz R, Porter D, Cihlar T, Feng JY. Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent. Antimicrob Agents Chemother 2021;65:e02237-20. [PMID: 33229429 DOI: 10.1128/AAC.02237-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
19 Li X, Wang Y, Bai Y, Xu J, Fu C, Kang Y, Cheng J, Shen Y, Liu J, Wu H, Zhang W, Li H, Li P, Gu J, Shao F, Wang M. PET/MR and PET/CT in a severe COVID-19 patient. Eur J Nucl Med Mol Imaging 2020;47:2478-9. [PMID: 32500167 DOI: 10.1007/s00259-020-04887-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
21 Samadder S. Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection. Front Public Health 2020;8:544993. [PMID: 33634060 DOI: 10.3389/fpubh.2020.544993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
23 Shurin MR, Morris A, Wells A, Wheeler SE. Assessing Immune Response to SARS-CoV-2 Infection. Immunotargets Ther 2020;9:111-4. [PMID: 32607314 DOI: 10.2147/ITT.S264138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Santana MF, Guerra MT, Hundt MA, Ciarleglio MM, Pinto RAA, Dutra BG, Xavier MS, Lacerda MVG, Ferreira AJ, Wanderley DC, Borges do Nascimento IJ, Araújo RFA, Pinheiro SVB, Araújo SA, Leite MF, Ferreira LCL, Nathanson MH, Vieira Teixeira Vidigal P. Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID-19 Infections in Brazil. Hepatol Commun 2021. [PMID: 34520633 DOI: 10.1002/hep4.1820] [Reference Citation Analysis]
25 Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020;510:475-82. [PMID: 32798514 DOI: 10.1016/j.cca.2020.08.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
26 Kang SH, Cho DH, Choi J, Baik SK, Gwon JG, Kim MY. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study. PLoS One 2021;16:e0258229. [PMID: 34610052 DOI: 10.1371/journal.pone.0258229] [Reference Citation Analysis]
27 Liu M, Han Y, Sun J, Wei X, Zhao X, Wang B, Zhang Y, Ma X, Gai Z. Comparison of the Epidemiological and Clinical Characteristics of Hospitalized Children With Pneumonia Caused by SARS-CoV-2, Influenza A, and Human Adenoviruses: A Case-Control Study. Clin Pediatr (Phila) 2021;:99228211058601. [PMID: 34753343 DOI: 10.1177/00099228211058601] [Reference Citation Analysis]
28 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med 2020;383:1827-37. [PMID: 32459919 DOI: 10.1056/NEJMoa2015301] [Cited by in Crossref: 525] [Cited by in F6Publishing: 315] [Article Influence: 262.5] [Reference Citation Analysis]
30 Chadalavada P, Padbidri V, Garg R, Alomari M, Babar A, Kewan T, Ahuja KR, Contreras J, Al-Jaghbeer MJ, Sanaka MR. Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. Cureus 2020;12:e11555. [PMID: 33365223 DOI: 10.7759/cureus.11555] [Reference Citation Analysis]
31 Pan L, Huang P, Xie X, Xu J, Guo D, Jiang Y. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis. Dig Liver Dis. 2021;53:153-157. [PMID: 33011088 DOI: 10.1016/j.dld.2020.09.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
32 Zhou M, Dong C, Li C, Wang Y, Liao H, Shi H, Lin AP, Wang J, Hu Y, Zheng C. Longitudinal changes in COVID-19 clinical measures and correlation with the extent of CT lung abnormalities. Int J Med Sci 2021;18:1277-84. [PMID: 33526989 DOI: 10.7150/ijms.51279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Aslan AT, Şimşek H. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations. Euroasian J Hepatogastroenterol 2021;11:81-6. [PMID: 34786361 DOI: 10.5005/jp-journals-10018-1347] [Reference Citation Analysis]
34 Aldhaleei WA, Alnuaimi A, Bhagavathula AS. COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates. Cureus. 2020;12:e8645. [PMID: 32550096 DOI: 10.7759/cureus.8645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
35 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
36 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Yeoman A, Maggs DR, Gardezi SAA, Haboubi HN, Yahya MI, Yousuf F, Czajkowski MA. Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales. Frontline Gastroenterol 2021;12:89-94. [PMID: 33617606 DOI: 10.1136/flgastro-2020-101532] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Kaffash Farkhad N, Reihani H, Sedaghat A, Moghadam AA, Moghadam AB, Tavakol-Afshari J. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regen Ther 2021;18:152-60. [PMID: 34124322 DOI: 10.1016/j.reth.2021.05.007] [Reference Citation Analysis]
39 Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol 2020;39:3245-54. [PMID: 32895747 DOI: 10.1007/s10067-020-05387-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
40 An Y, Ma Z, Guo X, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Zhao H, Lu H, Qi X. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study. Medicine (Baltimore) 2021;100:e25497. [PMID: 34106589 DOI: 10.1097/MD.0000000000025497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Brinati D, Campagner A, Ferrari D, Locatelli M, Banfi G, Cabitza F. Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study. J Med Syst 2020;44:135. [PMID: 32607737 DOI: 10.1007/s10916-020-01597-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 25.0] [Reference Citation Analysis]
42 Seow JJW, Pai R, Mishra A, Shepherdson E, Lim TKH, Goh BKP, Chan JKY, Chow PKH, Ginhoux F, DasGupta R, Sharma A. Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction. Front Med (Lausanne) 2021;8:603374. [PMID: 33968947 DOI: 10.3389/fmed.2021.603374] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
44 Piciucchi M, Sbrozzi-Vanni A, Rossi A, Satriano A, Dell'Amico I, Francesco V, Zullo A, Manta R. Preliminary considerations regarding the risk of COVID-19 and disease severity in chronic gastrointestinal conditions. Ann Gastroenterol 2020;33:327-9. [PMID: 32624651 DOI: 10.20524/aog.2020.0498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, Sakalli L, Alpdagtas S, Gunduz O, Ustundag CB. Combating COVID-19 with tissue engineering: a review. Emergent Mater 2020;:1-21. [PMID: 33235976 DOI: 10.1007/s42247-020-00138-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cherradi Y. CoVID-19: a Digestive Disease! JMSR. [DOI: 10.46327/msrjg.1.000000000000159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Tang G, Luo Y, Lu F, Li W, Liu X, Nan Y, Ren Y, Liao X, Wu S, Jin H, Zomaya AY, Sun Z. Prediction of Sepsis in COVID-19 Using Laboratory Indicators. Front Cell Infect Microbiol 2020;10:586054. [PMID: 33747973 DOI: 10.3389/fcimb.2020.586054] [Reference Citation Analysis]
48 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Elran-Barak R, Mozeikov M. One Month into the Reinforcement of Social Distancing due to the COVID-19 Outbreak: Subjective Health, Health Behaviors, and Loneliness among People with Chronic Medical Conditions. Int J Environ Res Public Health 2020;17:E5403. [PMID: 32727103 DOI: 10.3390/ijerph17155403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
50 Mohamadi M, Goodarzi A, Aryannejad A, Fattahi N, Alizadeh-Khoei M, Miri S, Hekmat H, Payab M, Bodaghabadi M. Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review. Med J Islam Repub Iran 2020;34:123. [PMID: 33437719 DOI: 10.34171/mjiri.34.123] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
51 Fujita Y, Hoshina T, Matsuzaki J, Yoshioka Y, Kadota T, Hosaka Y, Fujimoto S, Kawamoto H, Watanabe N, Sawaki K, Sakamoto Y, Miyajima M, Lee K, Nakaharai K, Horino T, Nakagawa R, Araya J, Miyato M, Yoshida M, Kuwano K, Ochiya T. Early prediction of COVID-19 severity using extracellular vesicle COPB2. J Extracell Vesicles 2021;10:e12092. [PMID: 34122778 DOI: 10.1002/jev2.12092] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Li Z, Liu T, Yang N, Han D, Mi X, Li Y, Liu K, Vuylsteke A, Xiang H, Guo X. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14:533-541. [PMID: 32367431 DOI: 10.1007/s11684-020-0786-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 40.5] [Reference Citation Analysis]
53 El-Ghiaty MA, Shoieb SM, El-Kadi AOS. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms. Med Hypotheses 2020;144:110033. [PMID: 32758877 DOI: 10.1016/j.mehy.2020.110033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
54 Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, Yang X, Zhou H, Li R, Ren Y, Chen X, Yao S, Qiu Y, Zhang DY, Xue Y, Shang Y, Zhou X. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity 2020;53:1108-1122.e5. [PMID: 33128875 DOI: 10.1016/j.immuni.2020.10.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
55 Dogra P, Ruiz-Ramírez J, Sinha K, Butner JD, Peláez MJ, Rawat M, Yellepeddi VK, Pasqualini R, Arap W, Sostman HD, Cristini V, Wang Z. Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model. ACS Pharmacol Transl Sci 2021;4:248-65. [PMID: 33615177 DOI: 10.1021/acsptsci.0c00183] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
56 Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, Yue H, Chen Z, Ma B, Liu D, Zhang L, Wang J, Xu D, Lei J, Li X, Huang H, Wang Y, Liu H, Yang J, Pan H, Liu W, Wang W, Li F, Zou S, Zhang H, Dong J. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020;73:455-458. [PMID: 32305291 DOI: 10.1016/j.jhep.2020.04.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 21.5] [Reference Citation Analysis]
57 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618. [PMID: 32439197 DOI: 10.1016/j.cpcardiol.2020.100618] [Cited by in Crossref: 286] [Cited by in F6Publishing: 268] [Article Influence: 143.0] [Reference Citation Analysis]
59 Olry A, Meunier L, Délire B, Larrey D, Horsmans Y, Le Louët H. Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same. Drug Saf 2020;43:615-7. [PMID: 32514859 DOI: 10.1007/s40264-020-00954-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
60 Lamazou F, Oger P, Dieli-Crimi R, Guerin A, Letouzey V, Octernaud S, Place V, Calès P, Descamps P, Delaroche L. COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. BMC Infect Dis 2020;20:845. [PMID: 33198681 DOI: 10.1186/s12879-020-05551-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Sutandyo N, Kurniawati SA, Jayusman AM, Syafiyah AH, Pranata R, Hanafi AR. Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19. PLoS One 2021;16:e0257775. [PMID: 34555104 DOI: 10.1371/journal.pone.0257775] [Reference Citation Analysis]
62 [DOI: 10.1101/2020.10.12.20211193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res 2020;290:198197. [PMID: 33069815 DOI: 10.1016/j.virusres.2020.198197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
64 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
65 Engin AB, Engin ED, Engin A. Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection. Environ Toxicol Pharmacol 2020;79:103436. [PMID: 32562764 DOI: 10.1016/j.etap.2020.103436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
66 Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxicol 2020;94:1367-9. [PMID: 32266419 DOI: 10.1007/s00204-020-02734-1] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
67 Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv 2021;7:eabg5995. [PMID: 34380619 DOI: 10.1126/sciadv.abg5995] [Reference Citation Analysis]
68 Youhanna S, Wright SC, Lauschke VM. Organotypic human ex vivo models for coronavirus disease 2019 research and drug development. Curr Opin Pharmacol 2021;59:11-8. [PMID: 34029832 DOI: 10.1016/j.coph.2021.04.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Lü M, Qiu L, Jia G, Guo R, Leng Q. Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2. Aging (Albany NY) 2020;12:19880-97. [PMID: 33104520 DOI: 10.18632/aging.104015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
70 Valdebenito S, Bessis S, Annane D, Lorin de la Grandmaison G, Cramer-Bordé E, Prideaux B, Eugenin EA, Bomsel M. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases. Front Immunol 2021;12:735922. [PMID: 34671353 DOI: 10.3389/fimmu.2021.735922] [Reference Citation Analysis]
71 Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, Iacucci M, Ng SC, Ghosh S, Mao R, Liang J. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Therap Adv Gastroenterol 2020;13:1756284820934626. [PMID: 32595762 DOI: 10.1177/1756284820934626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
72 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Debes JD. COVID-19 and the Liver: The Perils of Non-Peer-Reviewed Science in Times of a Pandemic. Gastroenterology 2020;159:1620. [PMID: 32283098 DOI: 10.1053/j.gastro.2020.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W, Yu K, Zhai Y. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 2021;13:6289-97. [PMID: 33711813 DOI: 10.18632/aging.202819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
76 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
77 Gholizadeh P, Safari R, Marofi P, Zeinalzadeh E, Pagliano P, Ganbarov K, Esposito S, Khodadadi E, Yousefi M, Samadi Kafil H. Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19). J Inflamm Res 2020;13:285-92. [PMID: 32669866 DOI: 10.2147/JIR.S257078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
78 Xia S, Wu M, Chen S, Zhang T, Ye L, Liu J, Li H. Long Term Culture of Human Kidney Proximal Tubule Epithelial Cells Maintains Lineage Functions and Serves as an Ex vivo Model for Coronavirus Associated Kidney Injury. Virol Sin 2020;35:311-20. [PMID: 32602046 DOI: 10.1007/s12250-020-00253-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
79 Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, Lin WB, Zhang GQ, Li GT, Cui GL, Wang FS. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study. BMC Infect Dis 2021;21:818. [PMID: 34399709 DOI: 10.1186/s12879-021-06572-z] [Reference Citation Analysis]
80 Canatan D, Vives Corrons JL, De Sanctis V. The Multifacets of COVID-19 in Adult Patients: A Concise Clinical Review on Pulmonary and Extrapulmonary Manifestations for Healthcare Physicians. Acta Biomed 2020;91:e2020173. [PMID: 33525226 DOI: 10.23750/abm.v91i4.10665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10:523-528. [PMID: 33194122 DOI: 10.1080/20009666.2020.1811556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
83 Krishnan A, Hamilton JP, Alqahtani SA, A Woreta T. A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med 2021;16:815-30. [PMID: 33453010 DOI: 10.1007/s11739-020-02616-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
84 Singh S, Khan A. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study. Gastroenterology. 2020;159:768-771.e3. [PMID: 32376408 DOI: 10.1053/j.gastro.2020.04.064] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 47.5] [Reference Citation Analysis]
85 Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN. SARS-CoV-2 Infection and the Liver. Pathogens. 2020;9. [PMID: 32486188 DOI: 10.3390/pathogens9060430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
86 Sarin SK. "Fast, faster, and fastest: science on the run during COVID-19 drama"-"do not forget the liver". Hepatol Int. 2020;14:454-455. [PMID: 32277386 DOI: 10.1007/s12072-020-10042-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
87 Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology.Neurogastroenterol Motil. 2021;33:e14104. [PMID: 33591607 DOI: 10.1111/nmo.14104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
88 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Hasan MZ, Islam S, Matsumoto K, Kawai T. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci Rep 2021;11:16814. [PMID: 34413339 DOI: 10.1038/s41598-021-96110-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB; AGA Institute. Electronic address: ewilson@gastro.org. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology 2020;159:739-758.e4. [PMID: 32247018 DOI: 10.1053/j.gastro.2020.03.072] [Cited by in Crossref: 161] [Cited by in F6Publishing: 126] [Article Influence: 80.5] [Reference Citation Analysis]
91 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Reference Citation Analysis]
92 Adam EH, Zacharowski K, Miesbach W. A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients. Thromb Res 2020;194:42-4. [PMID: 32723615 DOI: 10.1016/j.thromres.2020.06.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
93 Wang Z, Yang L. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021;270:113869. [PMID: 33485973 DOI: 10.1016/j.jep.2021.113869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
94 Bai Y, Xu J, Chen L, Fu C, Kang Y, Zhang W, Fakhri GE, Gu J, Shao F, Wang M. Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. Eur J Nucl Med Mol Imaging 2021;48:2531-42. [PMID: 33420914 DOI: 10.1007/s00259-020-05083-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
95 Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Hepatol Int. 2020;14:478-482. [PMID: 32440857 DOI: 10.1007/s12072-020-10051-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
96 An YW, Song S, Li WX, Chen YX, Hu XP, Zhao J, Li ZW, Jiang GY, Wang C, Wang JC, Yuan B, Liu HQ. Liver function recovery of COVID-19 patients after discharge, a follow-up study. Int J Med Sci. 2021;18:176-186. [PMID: 33390786 DOI: 10.7150/ijms.50691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
97 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]
98 Zhong ZF, Huang J, Yang X, Peng JL, Zhang XY, Hu Y, Fu N, Lin HL, Jiang B, Tian YY, Yao HY, Deng LP, Tang XQ, Zhou JC, Tang J, Xie X, Liu Q, Liu J, Dou CY, Dai RJ, Yan B, Yang XF. Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China. World J Clin Cases 2020; 8(12): 2554-2565 [PMID: 32607332 DOI: 10.12998/wjcc.v8.i12.2554] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
99 Aroniadis OC, DiMaio CJ, Dixon RE, Elmunzer BJ, Kolb JM, Mendelsohn R, Ordiah CO, Rockey DC, Singal AG, Spitzer RL, Tierney WM, Wani S, Yadav D; North American Alliance for the Study of Digestive Manifestations of Covid-19. Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19. Clin Gastroenterol Hepatol 2020;18:1682-4. [PMID: 32334083 DOI: 10.1016/j.cgh.2020.04.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
100 Reddy KR. SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections. Clin Liver Dis (Hoboken) 2020;15:191-4. [PMID: 32489654 DOI: 10.1002/cld.970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
101 Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, Zhang Y, Zhao Z, Xu H, Peng Z, Zhou F, Wang X. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine 2020;24:100426. [PMID: 32766541 DOI: 10.1016/j.eclinm.2020.100426] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
102 Xu J, Yang X, Huang C, Zou X, Zhou T, Pan S, Yang L, Wu Y, Ouyang Y, Wang Y, Xu D, Zhao X, Shu H, Jiang Y, Xiong W, Ren L, Liu H, Yuan Y, Qi H, Fu S, Chen D, Zhang D, Yuan S, Shang Y. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne) 2020;7:607821. [PMID: 33425951 DOI: 10.3389/fmed.2020.607821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
103 Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J 2020;11:505-15. [PMID: 32839667 DOI: 10.1007/s13167-020-00221-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
104 Gates LE, Hamed AA. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation. J Med Internet Res 2020;22:e21169. [PMID: 32735546 DOI: 10.2196/21169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
105 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
106 Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. bioRxiv 2020:2020. [PMID: 32511375 DOI: 10.1101/2020.05.08.084806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 8.5] [Reference Citation Analysis]
107 Su TH, Kao JH. The clinical manifestations and management of COVID-19-related liver injury. J Formos Med Assoc 2020;119:1016-8. [PMID: 32345544 DOI: 10.1016/j.jfma.2020.04.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
108 Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH. Management of liver diseases during the pandemic of coronavirus disease-19. Clin Mol Hepatol 2020;26:243-50. [PMID: 32570302 DOI: 10.3350/cmh.2020.0111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V. Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect? Ann Intensive Care 2021;11:44. [PMID: 33721137 DOI: 10.1186/s13613-021-00835-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
110 Bhatti AUR, Zreik J, Yolcu YU, Alvi MA, Abode-Iyamah K, Quinones-Hinojosa A, Bydon M. Nervous system involvement in SARS-coronavirus infection: a review on lessons learned from the previous outbreaks, ongoing pandemic and what to expect in the future. Int J Neurosci 2021;:1-10. [PMID: 33208006 DOI: 10.1080/00207454.2020.1853724] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Méndez-Sánchez N, Valencia-Rodríguez A, Qi X, Yoshida EM, Romero-Gómez M, George J, Eslam M, Abenavoli L, Xie W, Teschke R, Carrion AF, Keaveny AP. What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective. J Clin Transl Hepatol 2020;8:0024. [PMID: 32309152 DOI: 10.14218/JCTH.2020.00024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
112 Saavedra LPJ, Prates KV, Gonçalves GD, Piovan S, Matafome P, Mathias PCF. COVID-19 During Development: A Matter of Concern. Front Cell Dev Biol 2021;9:659032. [PMID: 33898461 DOI: 10.3389/fcell.2021.659032] [Reference Citation Analysis]
113 Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, Su X, Cao B. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517-1520. [PMID: 32311318 DOI: 10.1016/s0140-6736(20)30920-x] [Cited by in Crossref: 495] [Cited by in F6Publishing: 338] [Article Influence: 247.5] [Reference Citation Analysis]
114 Ramakrishna G, Kumar P, Aggarwal S, Islam M, Singh R, Jagdish RK, Trehanpati N. SARS-Cov-2 (human) and COVID-19: Primer 2020. Hepatol Int 2020;14:475-7. [PMID: 32333304 DOI: 10.1007/s12072-020-10049-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Debes JD, Anugwom CM, Aby ES. Systematic analysis of acute liver injury during SARS-CoV-2 infection.Dig Liver Dis. 2020;52:953-955. [PMID: 32487506 DOI: 10.1016/j.dld.2020.05.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Rando HM, MacLean AL, Lee AJ, Lordan R, Ray S, Bansal V, Skelly AN, Sell E, Dziak JJ, Shinholster L, D'Agostino McGowan L, Ben Guebila M, Wellhausen N, Knyazev S, Boca SM, Capone S, Qi Y, Park Y, Mai D, Sun Y, Boerckel JD, Brueffer C, Byrd JB, Kamil JP, Wang J, Velazquez R, Szeto GL, Barton JP, Goel RR, Mangul S, Lubiana T, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen, . Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure. mSystems 2021;6:e0009521. [PMID: 34698547 DOI: 10.1128/mSystems.00095-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. Management of patients with autoimmune liver disease during COVID-19 pandemic. J Hepatol. 2020;73:453-455. [PMID: 32283134 DOI: 10.1016/j.jhep.2020.04.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
118 Guler E, Unal NG, Cinkooglu A, Savas R, Kose T, Pullukcu H, Harman M, Elmas NZ, Ramaiya NH, Ozutemiz AO. Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans. Abdom Radiol (NY) 2021;46:1543-51. [PMID: 33051758 DOI: 10.1007/s00261-020-02805-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Wang C, Xu J, Wang S, Pan S, Zhang J, Han Y, Huang M, Wu D, Yang Q, Yang X, Yang Y, Shu T, Zou X, Li R, Luo Y, Yao R, Wang Y, Qiu Y, Wang Y, Zhang DY, Yao Q, Yan Y, Zhou X, Shang Y. Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients. Front Microbiol 2020;11:600989. [PMID: 33424804 DOI: 10.3389/fmicb.2020.600989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
120 Cao Y, Han X, Gu J, Li Y, Liu J, Alwalid O, Cui Y, Zhang X, Zheng C, Fan Y, Wu H, Shi H. Prognostic value of baseline clinical and HRCT findings in 101 patients with severe COVID-19 in Wuhan, China. Sci Rep 2020;10:17543. [PMID: 33067524 DOI: 10.1038/s41598-020-74497-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
121 Dilip Pandkar P, Sachdeva V. Pathophysiology of COVID-19 and Host centric approaches of Ayurveda. J Ayurveda Integr Med 2020. [PMID: 33519134 DOI: 10.1016/j.jaim.2020.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Tao Z, Li Y, Cheng B, Zhou T, Gao Y. Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease: A Meta-analysis. J Clin Gastroenterol 2021;55:830-5. [PMID: 34406175 DOI: 10.1097/MCG.0000000000001605] [Reference Citation Analysis]
123 Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes Metab Syndr 2020;14:671-7. [PMID: 32438331 DOI: 10.1016/j.dsx.2020.05.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 17.5] [Reference Citation Analysis]
124 Liu X, Mondal AM. Conditional cell reprogramming for modeling host-virus interactions and human viral diseases. J Med Virol 2020;92:2440-52. [PMID: 32478897 DOI: 10.1002/jmv.26093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Bizkarguenaga M, Bruzzone C, Gil-Redondo R, SanJuan I, Martin-Ruiz I, Barriales D, Palacios A, Pasco ST, González-Valle B, Laín A, Herrera L, Azkarate A, Vesga MA, Eguizabal C, Anguita J, Embade N, Mato JM, Millet O. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR Biomed 2021;:e4637. [PMID: 34708437 DOI: 10.1002/nbm.4637] [Reference Citation Analysis]
126 Raines NH, Ganatra S, Nissaisorakarn P, Pandit A, Morales A, Asnani A, Sadrolashrafi M, Maheshwari R, Patel R, Bang V, Shreyder K, Brar S, Singh A, Dani SS, Knapp S, Poyan Mehr A, Brown RS, Zeidel ML, Bhargava R, Schlondorff J, Steinman TI, Mukamal KJ, Parikh SM. Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study. Kidney360 2021;2:33-41. [DOI: 10.34067/kid.0006452020] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G, Schulze TG, Tondo L, Bauer M; International Group for The Study of Lithium Treated Patients (IGSLi). Lithium's antiviral effects: a potential drug for CoViD-19 disease? Int J Bipolar Disord 2020;8:21. [PMID: 32435920 DOI: 10.1186/s40345-020-00191-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
128 Zippi M, Fiorino S, Occhigrossi G, Hong W. Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis. World J Clin Cases 2020; 8(8): 1385-1390 [PMID: 32368531 DOI: 10.12998/wjcc.v8.i8.1385] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
129 Shiralkar K, Chinapuvvula N, Ocazionez D. Cross-Sectional Abdominal Imaging Findings in Patients With COVID-19. Cureus. 2020;12:e9538. [PMID: 32905406 DOI: 10.7759/cureus.9538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
130 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Deng ML, Chen YJ, Yang ML, Liu YW, Chen H, Tang XQ, Yang XF. COVID-19 combined with liver injury: Current challenges and management. World J Clin Cases 2021; 9(15): 3487-3497 [PMID: 34046449 DOI: 10.12998/wjcc.v9.i15.3487] [Reference Citation Analysis]
132 Mandal A, Konala VM, Adapa S, Naramala S, Gayam V. Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications. Cureus. 2020;12:e8750. [PMID: 32714688 DOI: 10.7759/cureus.8750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
133 Brooks MA. Editorial Comment on "Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19)". AJR Am J Roentgenol 2021;217:92. [PMID: 32936019 DOI: 10.2214/AJR.20.24644] [Reference Citation Analysis]
134 Ma Y, Zhu DS, Chen RB, Shi NN, Liu SH, Fan YP, Wu GH, Yang PY, Bai JF, Chen H, Chen LY, Feng Q, Guo TM, Hou Y, Hu GF, Hu XM, Hu YH, Huang J, Huang QH, Huang SZ, Ji L, Jin HH, Lei X, Li CY, Li MQ, Li QT, Li XY, Liu H, Liu JP, Liu Z, Ma YT, Mao Y, Mo LF, Na H, Wang JW, Song FL, Sun S, Wang DT, Wang MX, Wang XY, Wang YZ, Wang YD, Wu W, Wu LP, Xiao YH, Xie HJ, Xu HM, Xu SF, Xue RX, Yang C, Yang KJ, Yuan SL, Zhang GQ, Zhang JB, Zhang LS, Zhao SS, Zhao WY, Zheng K, Zhou YC, Zhu JT, Zhu TQ, Zhang HM, Wang YP, Wang YY; 'lung cleansing & detoxifying decoction' emergency project expert group for covid-19. Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China. Biomed Environ Sci 2020;33:893-905. [PMID: 33472729 DOI: 10.3967/bes2020.123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
136 Hoechter DJ, Becker-Pennrich A, Langrehr J, Bruegel M, Zwissler B, Schaefer S, Spannagl M, Hinske LC, Zoller M. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients. Thromb Res 2020;196:186-92. [PMID: 32891904 DOI: 10.1016/j.thromres.2020.08.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
137 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
138 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Hajivalili M, Hosseini M, Haji-Fatahaliha M. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges. Life Sci 2020;257:118058. [PMID: 32653518 DOI: 10.1016/j.lfs.2020.118058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
140 Aleem A, Mahadevaiah G, Shariff N, Kothadia JP. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness. Proc (Bayl Univ Med Cent) 2021;34:473-7. [PMID: 34219928 DOI: 10.1080/08998280.2021.1885289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Taneva G, Dimitrov D, Velikova T. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19. World J Hepatol 2021; 13(12): 2005-2012 [DOI: 10.4254/wjh.v13.i12.2005] [Reference Citation Analysis]
142 Puli S, Baig M, Walayat S. Gastrointestinal Symptoms and Elevation in Liver Enzymes in COVID-19 Infection: A Systematic Review and Meta-Analysis. Cureus. 2020;12:e9999. [PMID: 32983698 DOI: 10.7759/cureus.9999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Chen LZ, Lin ZH, Chen J, Liu SS, Shi T, Xin YN. Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19? Epidemiol Infect. 2020;148:e218. [PMID: 32951624 DOI: 10.1017/s0950268820002186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
144 Yung YL, Cheng CK, Chan HY, Xia JT, Lau KM, Wong RSM, Wu AKL, Chu RW, Wong ACC, Chow EYD, Yip SF, Leung JNS, Lee CK, Ng MHL. Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients. HLA 2021;97:127-32. [PMID: 33179437 DOI: 10.1111/tan.14135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
145 Ibrahim YS, Karuppasamy G, Parambil JV, Alsoub H, Al-Shokri SD. Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19. Am J Trop Med Hyg. 2020;103:1600-1603. [PMID: 32876011 DOI: 10.4269/ajtmh.20-0894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
146 Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5:529-530. [PMID: 32203680 DOI: 10.1016/s2468-1253(20)30084-4] [Cited by in Crossref: 206] [Cited by in F6Publishing: 156] [Article Influence: 103.0] [Reference Citation Analysis]
147 Philip M, Lakhtakia S, Aggarwal R, Madan K, Saraswat V, Makharia G. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19. J Clin Exp Hepatol. 2020;10:266-270. [PMID: 32362732 DOI: 10.1016/j.jceh.2020.04.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
148 Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, Bellmann-Weiler R, Joannidis M, Zoller H, Weiss G, Adolph TE, Tilg H. Systemic inflammation as fuel for acute liver injury in COVID-19. Dig Liver Dis. 2021;53:158-165. [PMID: 32873520 DOI: 10.1016/j.dld.2020.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
149 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
150 Chen P, Zhou B. Clinical characteristics of COVID-19 patients with abnormal liver tests. J Hepatol 2020;73:712-3. [PMID: 32348791 DOI: 10.1016/j.jhep.2020.04.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
151 Zhou F, Xia J, Yuan HX, Sun Y, Zhang Y. Liver injury in COVID-19: Known and unknown. World J Clin Cases 2021; 9(19): 4980-4989 [PMID: 34307548 DOI: 10.12998/wjcc.v9.i19.4980] [Reference Citation Analysis]
152 Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
153 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
154 Anjorin AA, Abioye AI, Asowata OE, Soipe A, Kazeem MI, Adesanya IO, Raji MA, Adesanya M, Oke FA, Lawal FJ, Kasali BA, Omotayo MO. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Health 2021;26:2-13. [PMID: 33012053 DOI: 10.1111/tmi.13504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
155 Liu Q, Li S, Dupuy A, Mai HL, Sailliet N, Logé C, Robert JH, Brouard S. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives. Int J Mol Sci 2021;22:7763. [PMID: 34360530 DOI: 10.3390/ijms22157763] [Reference Citation Analysis]
156 Farshidpour M, Kim D, Junna S, Merchant J. A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic. Indian J Gastroenterol 2020;39:232-5. [PMID: 32621206 DOI: 10.1007/s12664-020-01068-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 2020;81:205-12. [PMID: 32579986 DOI: 10.1016/j.jinf.2020.06.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
158 Zinellu A, Arru F, De Vito A, Sassu A, Valdes G, Scano V, Zinellu E, Perra R, Madeddu G, Carru C, Pirina P, Mangoni AA, Babudieri S, Fois AG. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients. Eur J Clin Invest 2021;51:e13427. [PMID: 33043447 DOI: 10.1111/eci.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
159 Lin H, Wu LJ, Guo SQ, Chen RL, Fan JR, Ke B, Pan ZQ. Dynamic monitoring of serum liver function indexes in patients with COVID-19. World J Clin Cases 2021; 9(7): 1554-1562 [PMID: 33728299 DOI: 10.12998/wjcc.v9.i7.1554] [Reference Citation Analysis]
160 Xu X, Yu MQ, Shen Q, Wang LZ, Yan RD, Zhang MY, Liu JY, Qu YQ. Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China. Int J Med Sci 2020;17:2052-62. [PMID: 32788884 DOI: 10.7150/ijms.47935] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
161 Hosier H, Farhadian SF, Morotti RA, Deshmukh U, Lu-Culligan A, Campbell KH, Yasumoto Y, Vogels CB, Casanovas-Massana A, Vijayakumar P, Geng B, Odio CD, Fournier J, Brito AF, Fauver JR, Liu F, Alpert T, Tal R, Szigeti-Buck K, Perincheri S, Larsen C, Gariepy AM, Aguilar G, Fardelmann KL, Harigopal M, Taylor HS, Pettker CM, Wyllie AL, Cruz CD, Ring AM, Grubaugh ND, Ko AI, Horvath TL, Iwasaki A, Reddy UM, Lipkind HS. SARS-CoV-2 infection of the placenta. J Clin Invest 2020;130:4947-53. [PMID: 32573498 DOI: 10.1172/JCI139569] [Cited by in Crossref: 140] [Cited by in F6Publishing: 90] [Article Influence: 70.0] [Reference Citation Analysis]
162 Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, Goldsmith CS, Silva-Flannery L, Seixas JN, Reagan-Steiner S, Uyeki T, Denison A, Bhatnagar J, Shieh WJ, Zaki SR;  COVID-19 Pathology Working Group. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerg Infect Dis. 2020;26:2005-2015. [PMID: 32437316 DOI: 10.3201/eid2609.202095] [Cited by in Crossref: 148] [Cited by in F6Publishing: 135] [Article Influence: 74.0] [Reference Citation Analysis]
163 Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol 2020; 26(19): 2323-2332 [PMID: 32476796 DOI: 10.3748/wjg.v26.i19.2323] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 47] [Article Influence: 30.0] [Reference Citation Analysis]
164 [DOI: 10.1101/2020.08.24.265645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
166 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
167 Puthiyedath R, Kataria S, Payyappallimana U, Mangalath P, Nampoothiri V, Sharma P, Singh MK, Kumar K, Trehan N. Ayurvedic clinical profile of COVID-19 - A preliminary report. J Ayurveda Integr Med 2020:S0975-9476(20)30039-5. [PMID: 32624376 DOI: 10.1016/j.jaim.2020.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
168 Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 [PMID: 33362383 DOI: 10.3748/wjg.v26.i46.7272] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
169 Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. The looming storm: Blood and cytokines in COVID-19. Blood Rev 2021;46:100743. [PMID: 32829962 DOI: 10.1016/j.blre.2020.100743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
170 Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, Polyakova IV, Bedretdinova ZS, Belikina DV, Lavrenyuk AA, Fomin IV. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med 2021;13:16-24. [PMID: 34603760 DOI: 10.17691/stm2021.13.4.02] [Reference Citation Analysis]
171 Ji D, Zhang D, Yang T, Mu J, Zhao P, Xu J, Li C, Cheng G, Wang Y, Chen Z, Qin E, Lau G. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020;14:701-710. [PMID: 32734407 DOI: 10.1007/s12072-020-10058-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
172 Wang MK, Yue HY, Cai J, Zhai YJ, Peng JH, Hui JF, Hou DY, Li WP, Yang JS. COVID-19 and the digestive system: A comprehensive review. World J Clin Cases 2021; 9(16): 3796-3813 [PMID: 34141737 DOI: 10.12998/wjcc.v9.i16.3796] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
173 Fabre JB, Grelot L, Vanbiervielt W, Mazerie J, Manca R, Martin V. Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport. BMJ Open Sport Exerc Med 2020;6:e000849. [PMID: 33194223 DOI: 10.1136/bmjsem-2020-000849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020; 26(48): 7693-7706 [PMID: 33505145 DOI: 10.3748/wjg.v26.i48.7693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
175 Hong X, He J, Li P, Chen J, Zou B, Li Z, Jia Y, Liu Y, Yang L, Li J. Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report. Ann Transl Med 2021;9:1631. [PMID: 34926675 DOI: 10.21037/atm-21-4778] [Reference Citation Analysis]
176 Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, Zhao Z, Jin S. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. Int J Environ Res Public Health 2021;18:E284. [PMID: 33401657 DOI: 10.3390/ijerph18010284] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
177 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
178 Omidi N, Forouzannia SK, Poorhosseini H, Tafti SHA, Salehbeigi S, Lotfi-Tokaldany M. Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about? J Card Surg 2020;35:2500-5. [PMID: 33043651 DOI: 10.1111/jocs.14707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 de Almeida SMV, Santos Soares JC, Dos Santos KL, Alves JEF, Ribeiro AG, Jacob ÍTT, da Silva Ferreira CJ, Dos Santos JC, de Oliveira JF, de Carvalho Junior LB, de Lima MDCA. COVID-19 therapy: What weapons do we bring into battle? Bioorg Med Chem 2020;28:115757. [PMID: 32992245 DOI: 10.1016/j.bmc.2020.115757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
180 Liu F, Liu H, Yu WY, Liu Z, Zhang X, Wang Y, Miao LB, Li ZY, Huang JS, Bao JF. The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients. Front Immunol 2021;12:717461. [PMID: 34552588 DOI: 10.3389/fimmu.2021.717461] [Reference Citation Analysis]
181 Pan Y, Li J, Xia X, Wang J, Jiang Q, Yang J, Dou H, Liang H, Li K, Hou Y. β-glucan-coupled superparamagnetic iron oxide nanoparticles induce trained immunity to protect mice against sepsis. Theranostics 2022;12:675-88. [PMID: 34976207 DOI: 10.7150/thno.64874] [Reference Citation Analysis]
182 Lobritto S, Danziger-Isakov L, Michaels MG, Mazariegos GV. Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs. Front Pediatr 2020;8:612627. [PMID: 33363069 DOI: 10.3389/fped.2020.612627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Grace JA, Casey S, Burrell LM, Angus PW. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis. Hepatol Int. 2020;14:884-885. [PMID: 32886332 DOI: 10.1007/s12072-020-10084-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
184 Goud PT, Bai D, Abu-Soud HM. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19. Int J Biol Sci 2021;17:62-72. [PMID: 33390833 DOI: 10.7150/ijbs.51811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
185 Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China. Hepatol Int. 2020;14:723-732. [PMID: 33026573 DOI: 10.1007/s12072-020-10075-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
186 Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. [PMID: 34239378 DOI: 10.31486/toj.20.0086] [Reference Citation Analysis]
187 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
188 Bender JM, Worman HJ. Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City. J Clin Transl Hepatol 2021;9:551-8. [PMID: 34447685 DOI: 10.14218/JCTH.2020.00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21:1107-1118. [PMID: 32788748 DOI: 10.1038/s41590-020-0762-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 77.5] [Reference Citation Analysis]
190 Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
191 Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals. World J Gastroenterol 2021; 27(34): 5630-5665 [PMID: 34629792 DOI: 10.3748/wjg.v27.i34.5630] [Reference Citation Analysis]
192 Singh M, Bansal V, Feschotte C. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. SSRN 2020;:3611279. [PMID: 32714119 DOI: 10.2139/ssrn.3611279] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Singh V, Choudhary A. Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia. Cureus 2021;13:e14986. [PMID: 34131531 DOI: 10.7759/cureus.14986] [Reference Citation Analysis]
194 Vitiello A, La Porta R, D'Aiuto V, Ferrara F. The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egypt Liver J 2021;11:11. [PMID: 34777865 DOI: 10.1186/s43066-021-00082-y] [Cited by in Crossref: 11] [Article Influence: 11.0] [Reference Citation Analysis]
195 Liu J, Liu S. The management of coronavirus disease 2019 (COVID-19). J Med Virol 2020;92:1484-90. [PMID: 32369222 DOI: 10.1002/jmv.25965] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
196 Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, Sun Y, Liu Y, He Q, Chen J, Liu L, Xu L. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73:566-574. [PMID: 32298767 DOI: 10.1016/j.jhep.2020.04.006] [Cited by in Crossref: 265] [Cited by in F6Publishing: 265] [Article Influence: 132.5] [Reference Citation Analysis]
197 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
198 Bernal-Monterde V, Casas-Deza D, Letona-Giménez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, Betoré-Glaria E, Martínez-de Lagos M, Martínez-Barredo L, Espinosa-Pérez M, M Arbones-Mainar J. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines 2020;8:E328. [PMID: 32899640 DOI: 10.3390/biomedicines8090328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
199 Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. 2020;19:353-358. [PMID: 32425991 DOI: 10.1016/j.aohep.2020.05.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
200 De Gottardi A, Fratila C, Bertoli R, Cerny A, Magenta L, Gianella P, Majno-Hurst P, Ceschi A, Vanini G, Bernasconi E. Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection. Clin Res Hepatol Gastroenterol 2020;44:e141-4. [PMID: 32565199 DOI: 10.1016/j.clinre.2020.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Wu M, Zou ZY, Chen YH, Wang C, Feng Y, Liu ZF. Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP). Chin J Traumatol 2021:S1008-1275(21)00182-6. [PMID: 34815141 DOI: 10.1016/j.cjtee.2021.11.001] [Reference Citation Analysis]
202 Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231-1240. [PMID: 32553666 DOI: 10.1016/j.jhep.2020.06.006] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 61.0] [Reference Citation Analysis]
203 Wang R, Kong L, Xu Q, Yang P, Wang X, Chen N, Li L, Jiang S, Lu X. On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study. Res Social Adm Pharm 2021;17:1853-8. [PMID: 33317764 DOI: 10.1016/j.sapharm.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
204 Lin X, Fu B, Yin S, Li Z, Liu H, Zhang H, Xing N, Wang Y, Xue W, Xiong Y, Zhang S, Zhao Q, Xu S, Zhang J, Wang P, Nian W, Wang X, Wu H. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience 2021;24:102293. [PMID: 33723527 DOI: 10.1016/j.isci.2021.102293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
205 Uzzan M, Corcos O, Martin JC, Treton X, Bouhnik Y. Why is SARS-CoV-2 infection more severe in obese men? Med Hypotheses. 2020;144:110023. [PMID: 32593832 DOI: 10.1016/j.mehy.2020.110023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
206 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
207 Shao T, Tong Y, Lu S, Jeyarajan AJ, Su F, Dai J, Shi J, Huang J, Hu C, Wu L, Dai X, Cheng Z, Yan J, Huang P, Tian Y, Li S, Chung RT, Chen D. γ-Glutamyltransferase Elevations Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study. Hepatol Commun 2020. [PMID: 32838106 DOI: 10.1002/hep4.1576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
208 Baldelli S, Corbellino M, Clementi E, Cattaneo D, Gervasoni C. Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? J Antimicrob Chemother 2020;75:2704-6. [PMID: 32407513 DOI: 10.1093/jac/dkaa190] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
209 Elhamzaoui H, Rebahi H, Hachimi A. Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review. Pan Afr Med J 2021;39:8. [PMID: 34178236 DOI: 10.11604/pamj.2021.39.8.23546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front Immunol 2020;11:1712. [PMID: 32754164 DOI: 10.3389/fimmu.2020.01712] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 34.0] [Reference Citation Analysis]
211 Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2:100113. [PMID: 32289115 DOI: 10.1016/j.jhepr.2020.100113] [Cited by in Crossref: 203] [Cited by in F6Publishing: 201] [Article Influence: 101.5] [Reference Citation Analysis]
212 Briguglio M, Pregliasco FE, Lombardi G, Perazzo P, Banfi G. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2. Front Med (Lausanne) 2020;7:146. [PMID: 32391367 DOI: 10.3389/fmed.2020.00146] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
213 Haji Esmaeil Memar E, Mamishi S, Sharifzadeh Ekbatani M, Alimadadi H, Yaghmaei B, Chegini V, Janani S, Mahmoudi S. Fulminant hepatic failure: A rare and devastating manifestation of Coronavirus disease 2019 in an 11-year-old boy. Arch Pediatr 2020;27:502-5. [PMID: 33069564 DOI: 10.1016/j.arcped.2020.09.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
214 Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C) 2020;2020:2402961. [PMID: 32377638 DOI: 10.34133/2020/2402961] [Cited by in Crossref: 71] [Cited by in F6Publishing: 89] [Article Influence: 35.5] [Reference Citation Analysis]
215 Cui X, Zhang T, Zheng J, Zhang J, Si P, Xu Y, Guo W, Liu Z, Li W, Ma J, Dong C, Shen Y, Cai C, He S. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients. J Med Virol 2020;92:1501-10. [PMID: 32418216 DOI: 10.1002/jmv.26023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
216 Fratta Pasini AM, Stranieri C, Girelli D, Busti F, Cominacini L. Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? Antioxidants (Basel) 2021;10:1677. [PMID: 34829548 DOI: 10.3390/antiox10111677] [Reference Citation Analysis]
217 Spogis J, Hagen F, Thaiss WM, Hoffmann T, Malek N, Nikolaou K, Berg CP, Singer S, Bösmüller H, Kreth F, Kaufmann S. Sonographic findings in coronavirus disease-19 associated liver damage. PLoS One 2021;16:e0244781. [PMID: 33606703 DOI: 10.1371/journal.pone.0244781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
219 La Mura V, Artoni A, Martinelli I, Rossio R, Gualtierotti R, Ghigliazza G, Fusco S, Ierardi AM, Andrisani MC, Carrafiello G, Peyvandi F. Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report. Am J Gastroenterol. 2020;115:1140-1142. [PMID: 32618673 DOI: 10.14309/ajg.0000000000000711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
220 Knight AC, Montgomery SA, Fletcher CA, Baxter VK. Mouse Models for the Study of SARS-CoV-2 Infection. Comp Med 2021;71:383-97. [PMID: 34610856 DOI: 10.30802/AALAS-CM-21-000031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Manhas S, Anjali A, Mansoor S, Sharma V, Ahmad A, Rehman MU, Ahmad P. Covid-19 Pandemic and Current Medical Interventions. Arch Med Res 2020;51:473-81. [PMID: 32499154 DOI: 10.1016/j.arcmed.2020.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
222 Ghasemiyeh P, Mohammadi-Samani S. COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection. Heart Lung 2020;49:763-73. [PMID: 32980626 DOI: 10.1016/j.hrtlng.2020.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
223 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, Coagulation, and Collateral Damage. J Immunol 2020;205:1488-95. [PMID: 32699160 DOI: 10.4049/jimmunol.2000644] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
225 Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut 2021:gutjnl-2020-323800. [PMID: 33514597 DOI: 10.1136/gutjnl-2020-323800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
226 Gornet JM, Tran Minh ML, Leleu F, Hassid D. [What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?]. J Chir Visc 2020;157:S52-9. [PMID: 32341722 DOI: 10.1016/j.jchirv.2020.04.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Verma S, Twilley D, Esmear T, Oosthuizen CB, Reid AM, Nel M, Lall N. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19). Front Pharmacol 2020;11:561334. [PMID: 33101023 DOI: 10.3389/fphar.2020.561334] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
228 Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World J Gastroenterol 2021; 27(22): 2944-2962 [PMID: 34168400 DOI: 10.3748/wjg.v27.i22.2944] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Lara-Ureña N, García-Domínguez M. Relevance of BET Family Proteins in SARS-CoV-2 Infection. Biomolecules 2021;11:1126. [PMID: 34439792 DOI: 10.3390/biom11081126] [Reference Citation Analysis]
230 Hachim MY, Hachim IY, Naeem KB, Hannawi H, Salmi IA, Hannawi S. D-dimer, Troponin, and Urea Level at Presentation With COVID-19 can Predict ICU Admission: A Single Centered Study. Front Med (Lausanne) 2020;7:585003. [PMID: 33363185 DOI: 10.3389/fmed.2020.585003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
231 Zheng X, Yang H, Li X, Li H, Xu L, Yu Q, Dong Y, Zhao Y, Wang J, Hou W, Zhang X, Li Y, Hu F, Gao H, Lv J, Yang L. Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19. Clin J Am Soc Nephrol 2020;15:1549-56. [PMID: 32943396 DOI: 10.2215/CJN.04780420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
232 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
233 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
234 Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF;  COVID-LT group. COVID-19 in an international European liver transplant recipient cohort. Gut. 2020;69:1832-1840. [PMID: 32571972 DOI: 10.1136/gutjnl-2020-321923] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
235 Chan SL, Kudo M. Impacts of COVID-19 on Liver Cancers: During and after the Pandemic. Liver Cancer. 2020;9:491-502. [PMID: 33078127 DOI: 10.1159/000510765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
236 Bhalerao A, Raut S, Noorani B, Mancuso S, Cucullo L. Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy. Cells 2021;10:2878. [PMID: 34831101 DOI: 10.3390/cells10112878] [Reference Citation Analysis]
237 Beraldo RF, Marcondes MB, Dos Santos MNM, Grillo TG, Pires GBT, de Oliveira CV. COVID-19 in a Patient with Liver Cirrhosis. Am J Case Rep 2021;22:e929948. [PMID: 33686051 DOI: 10.12659/AJCR.929948] [Reference Citation Analysis]
238 Gornet JM, Tran Minh ML, Leleu F, Hassid D. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19? J Visc Surg 2020;157:S51-7. [PMID: 32360205 DOI: 10.1016/j.jviscsurg.2020.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
239 Aldossary B, Hassan A, Moussa M, Alsaif HS, Alfaraj D. Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report. Int J Emerg Med 2021;14:24. [PMID: 33882839 DOI: 10.1186/s12245-021-00349-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Cao TT, Zhang GQ, Pellegrini E, Zhao Q, Li J, Luo LJ, Pan HQ. COVID-19 and its effects on the digestive system. World J Gastroenterol 2021; 27(24): 3502-3515 [PMID: 34239265 DOI: 10.3748/wjg.v27.i24.3502] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
241 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
242 Ali A, Hasan M, Hamed S, Elhamy A. Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity-a computed tomography study. Egypt Liver J 2021;11:61. [PMID: 34777870 DOI: 10.1186/s43066-021-00131-6] [Reference Citation Analysis]
243 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
244 Li S, Li J, Zhang Z, Tan L, Shao T, Li M, Li X, Holmes JA, Lin W, Han M. COVID-19 induced liver function abnormality associates with age. Aging (Albany NY) 2020;12:13895-904. [PMID: 32721928 DOI: 10.18632/aging.103720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
245 Thakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, Saxena SK, Devi M, Yadav D, Mehariya S. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med 2021;10:446. [PMID: 33498861 DOI: 10.3390/jcm10030446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
246 Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells 2021;10:1103. [PMID: 34064487 DOI: 10.3390/cells10051103] [Reference Citation Analysis]
247 Dara N, Sharifi N, Ghanbari Boroujeni M, Hosseini A, Sayyari A. COVID-19 pneumonia in a child with hepatic encephalopathy: A case study. Iran J Child Neurol 2021;15:113-8. [PMID: 33558820 DOI: 10.22037/ijcn.v15i1.30879] [Reference Citation Analysis]
248 Tu H, Zhao H, Su J, Wu W, Xu K, Hu J, Zhang X, Yang M, Sheng J. Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized Patients. Can J Infect Dis Med Microbiol 2021;2021:6213450. [PMID: 34691316 DOI: 10.1155/2021/6213450] [Reference Citation Analysis]
249 Huyut MT, Üstündağ H. Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: a retrospective observational study. Med Gas Res 2022;12:60-6. [PMID: 34677154 DOI: 10.4103/2045-9912.326002] [Reference Citation Analysis]
250 Lohia P, Kapur S, Benjaram S, Pandey A, Mir T, Seyoum B. Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter? J Diabetes 2021. [PMID: 33453090 DOI: 10.1111/1753-0407.13157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
251 Dong X, Sun L, Li Y. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19. Int J Med Sci 2020;17:2225-31. [PMID: 32922185 DOI: 10.7150/ijms.47604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
252 Ali E, Ziglam H, Kohla S, Ahmed M, Yassin M. A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2. Am J Case Rep. 2020;21:e925932. [PMID: 33046686 DOI: 10.12659/ajcr.925932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
253 Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022;322:C1-C11. [PMID: 34817268 DOI: 10.1152/ajpcell.00375.2021] [Reference Citation Analysis]
254 Radzina M, Putrins DS, Micena A, Vanaga I, Kolesova O, Platkajis A, Viksna L. Post-COVID-19 Liver Injury: Comprehensive Imaging With Multiparametric Ultrasound. J Ultrasound Med 2021. [PMID: 34241914 DOI: 10.1002/jum.15778] [Reference Citation Analysis]
255 Mirjalili M, Shafiekhani M, Vazin A. Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Ther Clin Risk Manag 2020;16:617-29. [PMID: 32694915 DOI: 10.2147/TCRM.S256246] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
256 Mokhtari AK, Maurer LR, Christensen MA, Moheb ME, Naar L, Alser O, Gaitanidis A, Langeveld K, Kapoen C, Breen K, Velmahos GC, Kaafarani HMA. Rhabdomyolysis in Severe COVID-19: Male Sex, High Body Mass Index, and Prone Positioning Confer High Risk. J Surg Res 2021;266:35-43. [PMID: 33975028 DOI: 10.1016/j.jss.2021.03.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Liu J, Yu C, Yang Q, Yuan X, Yang F, Li P, Chen G, Liang W, Yang Y. The clinical implication of gamma-glutamyl transpeptidase in COVID-19. Liver Res 2021. [PMID: 34603826 DOI: 10.1016/j.livres.2021.09.001] [Reference Citation Analysis]
258 Anirvan P, Singh SP, Giammarino A, Satapathy SK. Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. World J Hepatol 2021; 13(8): 916-925 [PMID: 34552698 DOI: 10.4254/wjh.v13.i8.916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Hu J, Wang Y. The Clinical Characteristics and Risk Factors of Severe COVID-19. Gerontology 2021;67:255-66. [PMID: 33406518 DOI: 10.1159/000513400] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
260 Hashizume M. Outlook of IL-6 signaling blockade for COVID-19 pneumonia. Inflamm Regen 2020;40:24. [PMID: 33024459 DOI: 10.1186/s41232-020-00134-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
261 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Reference Citation Analysis]
262 Poynard T, Deckmyn O, Rudler M, Peta V, Ngo Y, Vautier M, Akhavan S, Calvez V, Franc C, Castille JM, Drane F, Sakka M, Bonnefont-Rousselot D, Lacorte JM, Saadoun D, Allenbach Y, Benveniste O, Gandjbakhch F, Mayaux J, Lucidarme O, Fautrel B, Ratziu V, Housset C, Thabut D, Cacoub P. Performance of serum apolipoprotein-A1 as a sentinel of Covid-19. PLoS One 2020;15:e0242306. [PMID: 33216772 DOI: 10.1371/journal.pone.0242306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
263 Lam SM, Zhang C, Wang Z, Ni Z, Zhang S, Yang S, Huang X, Mo L, Li J, Lee B, Mei M, Huang L, Shi M, Xu Z, Meng FP, Cao WJ, Zhou MJ, Shi L, Chua GH, Li B, Cao J, Wang J, Bao S, Wang Y, Song JW, Zhang F, Wang FS, Shui G. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab 2021;3:909-22. [PMID: 34158670 DOI: 10.1038/s42255-021-00425-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
264 Nguyen MC, Lee EJ, Avery RK, Dioverti-Prono MV, Shoham S, Tobian AAR, Bloch EM, Gurakar A, Rizkalla NA, Cameron AM, King EA, Ottmann S, Garonzik-Wang JM, Wesson RN, Philosophe B. Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report. Transplant Direct 2021;7:e721. [PMID: 34258388 DOI: 10.1097/TXD.0000000000001178] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
265 Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO. Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano 2020;14:7760-82. [PMID: 32571007 DOI: 10.1021/acsnano.0c04006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 48.0] [Reference Citation Analysis]
266 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Angeles-Agdeppa I, Nacis JS, Capanzana MV, Dayrit FM, Tanda KV. Virgin coconut oil is effective in lowering C-reactive protein levels among suspect and probable cases of COVID-19. J Funct Foods 2021;83:104557. [PMID: 34055047 DOI: 10.1016/j.jff.2021.104557] [Reference Citation Analysis]
268 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Reference Citation Analysis]
269 Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970 [PMID: 33024752 DOI: 10.12998/wjcc.v8.i18.3956] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
270 Kimhofer T, Lodge S, Whiley L, Gray N, Loo RL, Lawler NG, Nitschke P, Bong SH, Morrison DL, Begum S, Richards T, Yeap BB, Smith C, Smith KGC, Holmes E, Nicholson JK. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection. J Proteome Res 2020;19:4442-54. [PMID: 32806897 DOI: 10.1021/acs.jproteome.0c00519] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 18.5] [Reference Citation Analysis]
271 Sriram K, Insel PA. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev 2021;101:545-67. [PMID: 33124941 DOI: 10.1152/physrev.00035.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
272 Coleman JJ, Manavi K, Marson EJ, Botkai AH, Sapey E. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med J 2020;96:392-8. [DOI: 10.1136/postgradmedj-2020-137979] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
273 Di Giorgio A, Nicastro E, Speziani C, De Giorgio M, Pasulo L, Magro B, Fagiuoli S, D' Antiga L. Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy. J Hepatol. 2020;73:702-705. [PMID: 32413378 DOI: 10.1016/j.jhep.2020.05.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
274 Speed V, Patel RK, Byrne R, Roberts LN, Arya R. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res 2020;192:73-4. [PMID: 32425265 DOI: 10.1016/j.thromres.2020.05.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
275 Yadlapati S, Lo KB, DeJoy R, Gul F, Peterson E, Bhargav R, Salacup GF, Pelayo J, Azmaiparashvilli Z, Patarroyo-Aponte G. Prevailing patterns of liver enzymes in patients with COVID-19 infection and association with clinical outcomes. Ann Gastroenterol 2021;34:224-8. [PMID: 33654363 DOI: 10.20524/aog.2021.0573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Cai Q, Chen J. Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests". J Hepatol 2020;73:713-4. [PMID: 32387074 DOI: 10.1016/j.jhep.2020.04.042] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
277 Belikina DV, Malysheva ES, Petrov AV, Nekrasova TA, Nekaeva ES, Lavrova AE, Zarubina DG, Atduev KA, Magomedova DM, Strongin LG. COVID-19 in Patients with Diabetes: Clinical Course, Metabolic Status, Inflammation, and Coagulation Disorder. Sovrem Tekhnologii Med 2021;12:6-16. [PMID: 34796000 DOI: 10.17691/stm2020.12.5.01] [Reference Citation Analysis]
278 Xue M, Zeng Y, Qu HQ, Zhang T, Li N, Huang H, Zheng P, Hu H, Zhou L, Duan Z, Zhang Y, Bao W, Tian LF, Hakonarson H, Zhong N, Zhang XD, Sun B. Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19. ERJ Open Res 2021;7:00741-2020. [PMID: 33564671 DOI: 10.1183/23120541.00741-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
279 Kazmi SK, Khan FMA, Natoli V, Hunain R, Islam Z, Costa ACDS, Ahmad S, Essar MY. Viral hepatitis amidst COVID-19 in Africa: Implications and recommendations. J Med Virol 2022;94:7-10. [PMID: 34506635 DOI: 10.1002/jmv.27330] [Reference Citation Analysis]
280 Hossain MF, Hasana S, Mamun AA, Uddin MS, Wahed MII, Sarker S, Behl T, Ullah I, Begum Y, Bulbul IJ, Amran MS, Rahman MH, Bin-Jumah MN, Alkahtani S, Mousa SA, Aleya L, Abdel-Daim MM. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management. Front Pharmacol 2020;11:563478. [PMID: 33178016 DOI: 10.3389/fphar.2020.563478] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
281 Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J Clin Med. 2020;9:3630. [PMID: 33187280 DOI: 10.3390/jcm9113630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
282 Nabavi S, Javidarabshahi Z, Allahyari A, Ramezani M, Seddigh-Shamsi M, Ravanshad S, AkbariRad M, Ebrahimzadeh F, Khatami S, Emadzadeh M, Saeedian N, Zarifian A, Miri M, Rezaeetalab F, Hejazi S, Basiri R, Mozdourian M. Clinical features and disease severity in an Iranian population of inpatients with COVID-19. Sci Rep 2021;11:8731. [PMID: 33888747 DOI: 10.1038/s41598-021-87917-1] [Reference Citation Analysis]
283 Brat GA, Weber GM, Gehlenborg N, Avillach P, Palmer NP, Chiovato L, Cimino J, Waitman LR, Omenn GS, Malovini A, Moore JH, Beaulieu-Jones BK, Tibollo V, Murphy SN, Yi SL, Keller MS, Bellazzi R, Hanauer DA, Serret-Larmande A, Gutierrez-Sacristan A, Holmes JJ, Bell DS, Mandl KD, Follett RW, Klann JG, Murad DA, Scudeller L, Bucalo M, Kirchoff K, Craig J, Obeid J, Jouhet V, Griffier R, Cossin S, Moal B, Patel LP, Bellasi A, Prokosch HU, Kraska D, Sliz P, Tan ALM, Ngiam KY, Zambelli A, Mowery DL, Schiver E, Devkota B, Bradford RL, Daniar M, Daniel C, Benoit V, Bey R, Paris N, Serre P, Orlova N, Dubiel J, Hilka M, Jannot AS, Breant S, Leblanc J, Griffon N, Burgun A, Bernaux M, Sandrin A, Salamanca E, Cormont S, Ganslandt T, Gradinger T, Champ J, Boeker M, Martel P, Esteve L, Gramfort A, Grisel O, Leprovost D, Moreau T, Varoquaux G, Vie JJ, Wassermann D, Mensch A, Caucheteux C, Haverkamp C, Lemaitre G, Bosari S, Krantz ID, South A, Cai T, Kohane IS. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med 2020;3:109. [PMID: 32864472 DOI: 10.1038/s41746-020-00308-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 18.5] [Reference Citation Analysis]
284 Weichmann F, Rohdewald P. Projected supportive effects of Pycnogenol in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection. Int J Antimicrob Agents 2020;56:106191. [PMID: 33045354 DOI: 10.1016/j.ijantimicag.2020.106191] [Reference Citation Analysis]
285 Atique M, Ghafoor A, Javed R, Fatima N, Yousaf A, Zahra S. Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients. Cureus 2021;13:e16655. [PMID: 34462686 DOI: 10.7759/cureus.16655] [Reference Citation Analysis]
286 Galiero R, Pafundi PC, Simeon V, Rinaldi L, Perrella A, Vetrano E, Caturano A, Alfano M, Beccia D, Nevola R, Marfella R, Sardu C, Coppola C, Scarano F, Maggi P, De Lucia Sposito P, Vocciante L, Rescigno C, Sbreglia C, Fraganza F, Parrella R, Romano A, Calabria G, Polverino B, Pagano A, Bologna C, Amitrano M, Esposito V, Coppola N, Maturo N, Adinolfi LE, Chiodini P, Sasso FC; COVOCA Study Group. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS One 2020;15:e0243700. [PMID: 33301529 DOI: 10.1371/journal.pone.0243700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
287 Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020;382:2327-2336. [PMID: 32275812 DOI: 10.1056/nejmoa2007016] [Cited by in Crossref: 1256] [Cited by in F6Publishing: 917] [Article Influence: 628.0] [Reference Citation Analysis]
288 Yao R, Zhu L, Wang J, Liu J, Xue R, Xue L, Liu L, Li C, Zhao H, Cheng J, Huang S, Li Y, Zhao XA, Zhu C, Li M, Huang R, Wu C. Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores. J Clin Lab Anal 2021;35:e23880. [PMID: 34213039 DOI: 10.1002/jcla.23880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Tao J, Aristotelidis R, Zanowick-Marr A, Chambers LC, McDonald J, Mylonakis EE, Chan PA. Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis. SN Compr Clin Med 2021;:1-12. [PMID: 34396045 DOI: 10.1007/s42399-021-01014-y] [Reference Citation Analysis]
290 Wang G, Wu S, Wu C, Zhang Q, Wu F, Yu B, Zhang S, Wu C, Wu G, Zhong Y. Association between non-alcoholic fatty liver disease with the susceptibility and outcome of COVID-19: A retrospective study. J Cell Mol Med 2021. [PMID: 34761514 DOI: 10.1111/jcmm.17042] [Reference Citation Analysis]
291 Dogra P, Ruiz-Ramírez J, Sinha K, Butner JD, Peláez MJ, Rawat M, Yellepeddi VK, Pasqualini R, Arap W, Sostman HD, Cristini V, Wang Z. Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model. medRxiv 2020:2020. [PMID: 33173913 DOI: 10.1101/2020.10.30.20215335] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
292 Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS. Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations. Transplant Proc. 2020;52:2601-2606. [PMID: 32586665 DOI: 10.1016/j.transproceed.2020.05.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
293 Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, Schulz WL, Taylor RA. Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation. Ann Emerg Med 2020;76:442-53. [PMID: 33012378 DOI: 10.1016/j.annemergmed.2020.07.022] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 32.5] [Reference Citation Analysis]
294 Hasani H, Mardi S, Shakerian S, Taherzadeh-Ghahfarokhi N, Mardi P. The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics. Biomed Res Int 2020;2020:3149020. [PMID: 32851061 DOI: 10.1155/2020/3149020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
295 Bende F, Tudoran C, Sporea I, Fofiu R, Bâldea V, Cotrău R, Popescu A, Sirli R, Ungureanu BS, Tudoran M. A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study. J Clin Med 2021;10:2507. [PMID: 34204032 DOI: 10.3390/jcm10112507] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
296 Qin C, Wei Y, Lyu X, Zhao B, Feng Y, Li T, Cao H, Yang X, Zhou X, Wang W, You L, Wang Y. High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients. Sci Rep 2020;10:16496. [PMID: 33020546 DOI: 10.1038/s41598-020-73575-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
297 Hammoudeh SM, Hammoudeh AM, Bhamidimarri PM, Mahboub B, Halwani R, Hamid Q, Rahmani M, Hamoudi R. Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World J Gastroenterol 2021; 27(21): 2850-2870 [PMID: 34135558 DOI: 10.3748/wjg.v27.i21.2850] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
298 Deng MC. Multi-dimensional COVID-19 short- and long-term outcome prediction algorithm. Expert Rev Precis Med Drug Dev 2020;5:239-42. [PMID: 33283045 DOI: 10.1080/23808993.2020.1785286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
299 Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304-307. [PMID: 32344011 DOI: 10.1016/j.ijid.2020.04.061] [Cited by in Crossref: 179] [Cited by in F6Publishing: 146] [Article Influence: 89.5] [Reference Citation Analysis]
300 Fang LG, Zhou Q. Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World J Clin Cases 2021; 9(19): 4969-4979 [PMID: 34307547 DOI: 10.12998/wjcc.v9.i19.4969] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Letelier P, Encina N, Morales P, Riffo A, Silva H, Riquelme I, Guzmán N. Role of biochemical markers in the monitoring of COVID-19 patients. J Med Biochem 2021;40:115-28. [PMID: 33776561 DOI: 10.5937/jomb0-29341] [Reference Citation Analysis]
302 Cao L, Zhang S, Wang E, Zhang Y, Bai Y, Luo X, Li Z, Li F, Tao L, Liu H. The CB index predicts prognosis of critically ill COVID-19 patients. Ann Transl Med 2020;8:1654. [PMID: 33490166 DOI: 10.21037/atm-20-7447] [Reference Citation Analysis]
303 Vitrone M, Mele F, Durante-Mangoni E, Zampino R. Drugs and liver injury: a not to be overlooked binomial in COVID-19. J Chemother 2021;:1-14. [PMID: 34644236 DOI: 10.1080/1120009X.2021.1988203] [Reference Citation Analysis]
304 Lee S, Channappanavar R, Kanneganti TD. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.Trends Immunol. 2020;41:1083-1099. [PMID: 33153908 DOI: 10.1016/j.it.2020.10.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 19.5] [Reference Citation Analysis]
305 Zeng QQ, Zheng KI, Chen J, Jiang ZH, Tian T, Wang XB, Ma HL, Pan KH, Yang YJ, Chen YP, Zheng MH. Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia. MedComm (Beijing) 2020. [PMID: 32838396 DOI: 10.1002/mco2.14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
306 Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X. Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19. Front Med (Lausanne). 2020;7:584342. [PMID: 33195339 DOI: 10.3389/fmed.2020.584342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
307 Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, Maiorana A, Silvestri G, Giannico GA. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614-33. [PMID: 34031537 DOI: 10.1038/s41379-021-00814-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
308 Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol. 2020;26:562-576. [PMID: 33053932 DOI: 10.3350/cmh.2020.0126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
309 Bansal R, Gubbi S, Muniyappa R. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course. Endocrinology. 2020;161. [PMID: 32603424 DOI: 10.1210/endocr/bqaa112] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
310 Lem FF, Opook F, Lee DJH, Chee FT, Lawson FP, Chin SN. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review. Front Pharmacol 2020;11:585331. [PMID: 33746739 DOI: 10.3389/fphar.2020.585331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol 2020;15:1287-305. [PMID: 32851877 DOI: 10.2217/fmb-2020-0110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
312 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
313 Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases 2020; 8(16): 3405-3410 [PMID: 32913847 DOI: 10.12998/wjcc.v8.i16.3405] [Reference Citation Analysis]
314 Liu Z, Wang J, Ge Y, Xu Y, Guo M, Mi K, Xu R, Pei Y, Zhang Q, Luan X, Hu Z, Chi Y, Liu X. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response. J Biomed Res 2021;35:216-27. [PMID: 33963094 DOI: 10.7555/JBR.35.20200154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Kukla M, Skonieczna-Żydecka K, Kotfis K, Maciejewska D, Łoniewski I, Lara LF, Pazgan-Simon M, Stachowska E, Kaczmarczyk M, Koulaouzidis A, Marlicz W. COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature. J Clin Med 2020;9:E1420. [PMID: 32403255 DOI: 10.3390/jcm9051420] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
316 Yamazaki S, Suzuki T, Sayama M, Nakada TA, Igari H, Ishii I. Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19. J Infect Chemother 2021;27:390-2. [PMID: 33402301 DOI: 10.1016/j.jiac.2020.12.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
317 Bhayana R, Som A, Li MD, Carey DE, Anderson MA, Blake MA, Catalano O, Gee MS, Hahn PF, Harisinghani M, Kilcoyne A, Lee SI, Mojtahed A, Pandharipande PV, Pierce TT, Rosman DA, Saini S, Samir AE, Simeone JF, Gervais DA, Velmahos G, Misdraji J, Kambadakone A. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020;297:E207-E215. [PMID: 32391742 DOI: 10.1148/radiol.2020201908] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 60.5] [Reference Citation Analysis]
318 Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B, Routy JP. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System. Front Immunol 2020;11:596631. [PMID: 33384690 DOI: 10.3389/fimmu.2020.596631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
320 Ma GG, Shen YX, Wu L, Luo Z, Zhu CW, Chen SY, Yu KH, Li F. Effect of liver injury on prognosis and treatment of hospitalized patients with COVID-19 pneumonia. Ann Transl Med 2021;9:10. [PMID: 33553303 DOI: 10.21037/atm-20-4850] [Reference Citation Analysis]
321 Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, Mandavdhare HS, Dutta U, Sharma V. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int 2020;14:711-22. [PMID: 32623633 DOI: 10.1007/s12072-020-10071-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
322 Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother 2021;133:111064. [PMID: 33378966 DOI: 10.1016/j.biopha.2020.111064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
323 Testino G. Covid-19 infection, liver injury and prognosis: a suggestion. Eur J Gastroenterol Hepatol 2021;33:451-2. [PMID: 32558696 DOI: 10.1097/MEG.0000000000001809] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
325 Karuppan MKM, Devadoss D, Nair M, Chand HS, Lakshmana MK. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism. Mol Neurobiol 2021;58:2465-80. [PMID: 33439437 DOI: 10.1007/s12035-020-02245-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
326 Abeysekera KW, Karteszi H, Clark A, Gordon FH. Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection. BMJ Case Rep 2020;13:e238906. [PMID: 33371000 DOI: 10.1136/bcr-2020-238906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 Ramkissoon R, Wang XJ. The Impact of COVID-19 in Gastroenterology and Hepatology. J Clin Gastroenterol 2021;55:757-65. [PMID: 34420001 DOI: 10.1097/MCG.0000000000001600] [Reference Citation Analysis]
328 Paladino L, Vitale AM, Caruso Bavisotto C, Conway de Macario E, Cappello F, Macario AJL, Gammazza AM. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19. J Clin Med 2020;9:E3518. [PMID: 33143379 DOI: 10.3390/jcm9113518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
329 Kalal CR, Joshi H, Kumar V, Gopal D, Rathod D, Shukla A, Gianchandani T, Bhatt C. Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India. J Clin Transl Hepatol 2021;9:878-88. [PMID: 34966651 DOI: 10.14218/JCTH.2020.00099] [Reference Citation Analysis]
330 Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y, Zhou T, Yuan Y, Qi H, Fu S, Liu H, Xia J, Xu Z, Yu Y, Li R, Ouyang Y, Wang R, Ren L, Hu Y, Xu D, Zhao X, Yuan S, Zhang D, Shang Y. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care 2020;24:394. [PMID: 32631393 DOI: 10.1186/s13054-020-03098-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 32.0] [Reference Citation Analysis]
331 Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW. Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience. Liver Int. 2020;40:2515-2521. [PMID: 32585065 DOI: 10.1111/liv.14583] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 19.0] [Reference Citation Analysis]
332 Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR. How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? Front Med (Lausanne) 2020;7:398. [PMID: 32754608 DOI: 10.3389/fmed.2020.00398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
333 Balaja WR 3rd, Jacob S, Hamidpour S, Masoud A. COVID-19 Presenting as Acute Icteric Hepatitis. Cureus 2021;13:e16359. [PMID: 34395136 DOI: 10.7759/cureus.16359] [Reference Citation Analysis]
334 Huang R, Zhu L, Wang J, Xue L, Liu L, Yan X, Huang S, Li Y, Yan X, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Wang Y, Zhao H, Hong S, Chen K, Zhao XA, Zou L, Sang D, Shao H, Guan X, Chen X, Chen Y, Wei J, Zhu C, Wu C. Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. Hepatol Commun 2020. [PMID: 32838108 DOI: 10.1002/hep4.1592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
335 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
336 Crespo J, Andrade R, Alberca de Las Parras F, Balaguer F, Barreiro-de Acosta M, Bujanda L, Gutiérrez A, Jorquera F, Iglesias-García J, Sánchez-Yagüe A, Calleja JL. Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG. Gastroenterol Hepatol 2020;43:332-47. [PMID: 32409107 DOI: 10.1016/j.gastrohep.2020.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
337 Essa RA, Ahmed SK, Bapir DH, Abubakr CP. Hyperbilirubinemia with mild COVID-19 patient: A case report. Int J Surg Case Rep 2021;82:105958. [PMID: 33968603 DOI: 10.1016/j.ijscr.2021.105958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
338 Lei P, Zhang L, Han P, Zheng C, Tong Q, Shang H, Yang F, Hu Y, Li X, Song Y. Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury. Hepatol Int. 2020;14:733-742. [PMID: 32886333 DOI: 10.1007/s12072-020-10087-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
339 Ali N. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients? Clin Res Hepatol Gastroenterol. 2020;44:e84-e86. [PMID: 32471656 DOI: 10.1016/j.clinre.2020.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
340 Currier EE, Dabaja M, Jafri SM. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2. World J Hepatol 2021; 13(9): 1181-1189 [PMID: 34630884 DOI: 10.4254/wjh.v13.i9.1181] [Reference Citation Analysis]
341 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Reference Citation Analysis]
342 Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med (Lausanne) 2020;7:526. [PMID: 32903492 DOI: 10.3389/fmed.2020.00526] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
343 Tuttle KD, Waugh KA, Araya P, Minter R, Orlicky DJ, Ludwig M, Andrysik Z, Burchill MA, Tamburini BAJ, Sempeck C, Smith K, Granrath R, Tracy D, Baxter J, Espinosa JM, Sullivan KD. JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. Cell Rep 2020;33:108407. [PMID: 33207208 DOI: 10.1016/j.celrep.2020.108407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
344 Triki H, Jeddou H, Boudjema K. Surgical resection for liver cancer during the COVID-19 outbreak. Updates Surg 2020;72:305-7. [PMID: 32436017 DOI: 10.1007/s13304-020-00799-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
345 Bonam SR, Muller S, Bayry J, Klionsky DJ. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy 2020;16:2260-6. [PMID: 32522067 DOI: 10.1080/15548627.2020.1779467] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
346 [DOI: 10.1101/2020.10.22.20216317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
347 Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020;26:1306-1314. [PMID: 32720978 DOI: 10.1093/ibd/izaa181] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
348 Berry SK, Fontana RJ. Potential Treatments for SARS-CoV-2 Infection. Clin Liver Dis (Hoboken) 2020;15:181-6. [PMID: 32537133 DOI: 10.1002/cld.969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
349 Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, Fantone F, Pace M, Garofalo F. Gastrointestinal involvement in paediatric COVID-19 — from pathogenesis to clinical management: A comprehensive review. World J Gastroenterol 2021; 27(23): 3303-3316 [PMID: 34163113 DOI: 10.3748/wjg.v27.i23.3303] [Reference Citation Analysis]
350 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
351 Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med 2020;9:E1753. [PMID: 32516940 DOI: 10.3390/jcm9061753] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 36.0] [Reference Citation Analysis]
352 Kehar M, Ebel NH, Ng VL, Baquero JER, Leung DH, Slowik V, Ovchinsky N, Shah AA, Arnon R, Miloh T, Gupta N, Mohammad S, Kogan-Liberman D, Squires JE, Sanchez MC, Hildreth A, Book L, Chu C, Alrabadi L, Azzam R, Chepuri B, Elisofon S, Falik R, Gallagher L, Kader H, Mogul D, Mujawar Q, Namjoshi SS, Valentino PL, Vitola B, Waheed N, Zheng MH, Lobritto S, Martinez M. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr 2021;72:807-14. [PMID: 33605666 DOI: 10.1097/MPG.0000000000003077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
353 Xiao Y, Pan H, She Q, Wang F, Chen M. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis. Lancet Gastroenterol Hepatol 2020;5:528-9. [PMID: 32197093 DOI: 10.1016/S2468-1253(20)30080-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
354 Li Y, Wang Y, Liu H, Sun W, Ding B, Zhao Y, Chen P, Zhu L, Li Z, Li N, Chang L, Wang H, Bai C, Xu P. Urine proteome of COVID-19 patients. Urine (Amst) 2020;2:1-8. [PMID: 33688631 DOI: 10.1016/j.urine.2021.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
355 Bartoletti-Stella A, Gatta V, Mariani GA, Gobbi P, Falconi M, Manzoli L, Faenza I, Salucci S. Three-Dimensional Virtual Anatomy as a New Approach for Medical Student's Learning. Int J Environ Res Public Health 2021;18:13247. [PMID: 34948857 DOI: 10.3390/ijerph182413247] [Reference Citation Analysis]
356 Effenberger M, Grander C, Fritsche G, Bellmann-Weiler R, Hartig F, Wildner S, Seiwald S, Adolph TE, Zoller H, Weiss G, Tilg H. Liver stiffness by transient elastography accompanies illness severity in COVID-19. BMJ Open Gastroenterol. 2020;7. [PMID: 32665398 DOI: 10.1136/bmjgast-2020-000445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
357 Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Sanchis-Gomar F, Carbonell N, García-Giménez JL. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.Antioxidants (Basel). 2020;9:936. [PMID: 33003552 DOI: 10.3390/antiox9100936] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
358 Mahajan RK, Paul G, Mahajan R, Gautam PL, Paul B. Systemic manifestations of COVID-19. J Anaesthesiol Clin Pharmacol 2020;36:435-42. [PMID: 33840920 DOI: 10.4103/joacp.JOACP_359_20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
359 Mokhtari NB, Drassinower D, Orr LA, Cobb NK, Mims OL Jr, Landy HJ. Expectant Management of Severe COVID-19 Pneumonia in Late Preterm Pregnancy and Subsequent Cholecystitis: Lessons Learned. AJP Rep 2021;11:e29-33. [PMID: 33598363 DOI: 10.1055/s-0040-1721672] [Reference Citation Analysis]
360 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
361 Li J, Fan JG. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. J Clin Transl Hepatol 2020;8:13-7. [PMID: 32274341 DOI: 10.14218/JCTH.2020.00019] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 47.0] [Reference Citation Analysis]
362 Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol 2020;99:1953-65. [PMID: 32671455 DOI: 10.1007/s00277-020-04182-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
363 Sinz S, Glaser-Gallion F, Steffen T. Portal vein thrombosis in COVID-19 infection. Surg Case Rep 2021;7:87. [PMID: 33830380 DOI: 10.1186/s40792-021-01173-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Rauf A, Abu-Izneid T, Olatunde A, Ahmed Khalil A, Alhumaydhi FA, Tufail T, Shariati MA, Rebezov M, Almarhoon ZM, Mabkhot YN, Alsayari A, Rengasamy KRR. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. Int J Environ Res Public Health 2020;17:E8155. [PMID: 33158234 DOI: 10.3390/ijerph17218155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
365 Oikonomou KG, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A, Bouliaris K, Papamichalis M, Karvouniaris M, Vlachostergios PJ, Skoura AL, Komnos A. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World J Clin Cases 2021; 9(19): 4918-4938 [PMID: 34307544 DOI: 10.12998/wjcc.v9.i19.4918] [Reference Citation Analysis]
366 Ahmed M, Ahmed MH. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142 [PMID: 34141776 DOI: 10.12998/wjcc.v9.i17.4133] [Reference Citation Analysis]
367 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
368 Liu XQ, Xue S, Xu JB, Ge H, Mao Q, Xu XH, Jiang HD. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China. Acta Pharmacol Sin 2021. [PMID: 33742107 DOI: 10.1038/s41401-021-00627-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol 2020;177:4353-74. [PMID: 32681537 DOI: 10.1111/bph.15204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
370 Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol 2020;19:627-34. [PMID: 32882393 DOI: 10.1016/j.aohep.2020.08.064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
371 Lin Y, Yuan J, Long Q, Hu J, Deng H, Zhao Z, Chen J, Lu M, Huang A. Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury. Genes Dis. 2020;. [PMID: 33225036 DOI: 10.1016/j.gendis.2020.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
372 Cantini F, Goletti D, Petrone L, Najafi Fard S, Niccoli L, Foti R. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs. 2020;80:1929-1946. [PMID: 33068263 DOI: 10.1007/s40265-020-01421-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
373 Soltani Zangbar H, Gorji A, Ghadiri T. A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View. Mol Neurobiol 2021;58:536-49. [PMID: 32981023 DOI: 10.1007/s12035-020-02149-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
374 Williams TL, Strachan G, Macrae RGC, Kuc RE, Nyimanu D, Paterson AL, Sinha S, Maguire JJ, Davenport AP. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites. Sci Rep 2021;11. [DOI: 10.1038/s41598-021-03731-9] [Reference Citation Analysis]
375 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
376 Sy-Janairo ML, Y Cua IH. Association of metabolic-associated fatty liver disease and risk of severe coronavirus disease 2019 illness.JGH Open. 2020;. [PMID: 33363258 DOI: 10.1002/jgh3.12465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
377 Hartog N, Faber W, Frisch A, Bauss J, Bupp CP, Rajasekaran S, Prokop JW. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Rev Proteomics 2021;18:105-18. [PMID: 33779460 DOI: 10.1080/14789450.2021.1908894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Boraschi P, Giugliano L, Mercogliano G, Donati F, Romano S, Neri E. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol 2021; 27(26): 4143-4159 [PMID: 34326615 DOI: 10.3748/wjg.v27.i26.4143] [Reference Citation Analysis]
379 Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37. [PMID: 32879731 DOI: 10.1186/s40364-020-00217-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
380 Bernstein D, Roth N, Kim A, Epstein M, Hirschwerk D, Kvasnovsky CL, Satapathy SK. Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease. World J Gastroenterol 2021; 27(42): 7350-7361 [PMID: 34876794 DOI: 10.3748/wjg.v27.i42.7350] [Reference Citation Analysis]
381 Sun G, Zhang Y, Liao Q, Cheng Y. Blood Test Results of Pregnant COVID-19 Patients: An Updated Case-Control Study. Front Cell Infect Microbiol 2020;10:560899. [PMID: 33117727 DOI: 10.3389/fcimb.2020.560899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
382 Kunutsor SK, Laukkanen JA. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis. J Infect 2021;82:159-98. [PMID: 32474033 DOI: 10.1016/j.jinf.2020.05.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
383 Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ. Gastrointestinal and Liver Manifestations of COVID-19. J Clin Exp Hepatol. 2020;10:263-265. [PMID: 32405183 DOI: 10.1016/j.jceh.2020.03.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 19.5] [Reference Citation Analysis]
384 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
385 Cheong J, Bartell N, Peeraphatdit T, Mosli M, Al-Judaibi B. Gastrointestinal and liver manifestations of COVID-19. Saudi J Gastroenterol 2020;26:226-32. [PMID: 32367837 DOI: 10.4103/sjg.SJG_147_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
386 Vespa E, Pugliese N, Colapietro F, Aghemo A. Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations. Tech Innov Gastrointest Endosc. 2021;23:179-189. [PMID: 33521703 DOI: 10.1016/j.tige.2021.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
387 Shi YJ, Wang H. Progress in the diagnosis and treatment of COVID-19 and the role of surgeons in the front line of the pandemic. Surg Today 2020;50:1544-8. [PMID: 32886210 DOI: 10.1007/s00595-020-02090-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
388 Liu D, Zhang Q, Bai P, Zhao J. Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease. J Hepatol 2021:S0168-8278(21)02218-2. [PMID: 34813919 DOI: 10.1016/j.jhep.2021.11.014] [Reference Citation Analysis]
389 Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, Marzolini C, Siccardi M, Burger D, Gibbons S, Khoo S, Back D. Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs R D 2021;21:9-27. [PMID: 33336316 DOI: 10.1007/s40268-020-00333-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
390 Altaf A, Abbas Z, Mandviwalla HA, Qadeer MA, Siyal M, Tariq M, Ghafoor A, Karamat M, Shahid B, Ali M. Severe COVID-19 Associated With Liver Injury in Patients Without Preexisting Liver Disease. Cureus. 2021;13:e14705. [PMID: 34055545 DOI: 10.7759/cureus.14705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Ali N. Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Front Med (Lausanne) 2020;7:458. [PMID: 32793619 DOI: 10.3389/fmed.2020.00458] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
392 Xiao Y, Wu D, Shi X, Liu S, Hu X, Zhou C, Tian X, Liu H, Long H, Li Z, Wang J, Tan T, Xu Y, Chen B, Liu T, Zhang H, Zheng S, Hu S, Song J, Tang J, Song J, Cheng Z, Xu W, Shen Y, Yu W, Xu Y, Li J, Zhou J, Wang F, Chen M. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence 2021;12:1199-208. [PMID: 33870852 DOI: 10.1080/21505594.2021.1909894] [Reference Citation Analysis]
393 Santenna C, Vidyasagar K, Amarneni KC, Ghanta SN, Sadasivam B, Pathan S, Padmavathi R. The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis. Ther Adv Drug Saf 2021;12:20420986211042517. [PMID: 34594487 DOI: 10.1177/20420986211042517] [Reference Citation Analysis]
394 Rahmani H, Davoudi-Monfared E, Nourian A, Nabiee M, Sadeghi S, Khalili H, Abbasian L, Ghiasvand F, Seifi A, Hasannezhad M, Ghaderkhani S, Mohammadi M, Yekaninejad MS. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru 2020;28:625-34. [PMID: 32857301 DOI: 10.1007/s40199-020-00369-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
395 Narang K, Enninga EAL, Gunaratne MDSK, Ibirogba ER, Trad ATA, Elrefaei A, Theiler RN, Ruano R, Szymanski LM, Chakraborty R, Garovic VD. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc 2020;95:1750-65. [PMID: 32753148 DOI: 10.1016/j.mayocp.2020.05.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 20.5] [Reference Citation Analysis]
396 Bashash D, Olfatifar M, Hadaegh F, Asadzadeh Aghdaei H, Zali MR. COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection. Gastroenterol Hepatol Bed Bench. 2020;13:313-320. [PMID: 33244373 DOI: 10.22037/ghfbb.v13i4.2002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
397 Singh M, Bansal V, Feschotte C. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. Cell Rep 2020;32:108175. [PMID: 32946807 DOI: 10.1016/j.celrep.2020.108175] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 36.5] [Reference Citation Analysis]
398 Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H, Arjmand B. Recent Advances of COVID-19 Modeling Based on Regenerative Medicine. Front Cell Dev Biol 2021;9:683619. [PMID: 34760882 DOI: 10.3389/fcell.2021.683619] [Reference Citation Analysis]
399 Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res 2021;26:84. [PMID: 34344463 DOI: 10.1186/s40001-021-00563-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
400 Turski WA, Wnorowski A, Turski GN, Turski CA, Turski L. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives. Restor Neurol Neurosci 2020;38:343-54. [PMID: 32597823 DOI: 10.3233/RNN-201042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
401 Yang L, Tian D, Han JB, Fan W, Zhang Y, Li Y, Sun W, Wei Y, Tian X, Yu DD, Feng XL, Cheng G, Bi Y, Zheng YT, Liu W. A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates. Innovation (N Y) 2021;2:100140. [PMID: 34179862 DOI: 10.1016/j.xinn.2021.100140] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Pence BD. Severe COVID-19 and aging: are monocytes the key? Geroscience 2020;42:1051-61. [PMID: 32556942 DOI: 10.1007/s11357-020-00213-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 26.5] [Reference Citation Analysis]
403 Rhee Y, Chan EL, Eswaran SL, Aloman C, Hertl M, Santos CAQ. Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant. Clin Liver Dis (Hoboken) 2020;15:246-50. [PMID: 32617159 DOI: 10.1002/cld.990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Alirezaei S, Vatanchi A, Pourali L, Aminzadeh B, Latifnejad Roudsari R. Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings. BMC Infect Dis 2021;21:678. [PMID: 34256733 DOI: 10.1186/s12879-021-06175-8] [Reference Citation Analysis]
405 Webb GJ, Moon AM, Barnes E, Barritt AS, Marjot T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol 2020;5:643-4. [PMID: 32339474 DOI: 10.1016/S2468-1253(20)30125-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 26.5] [Reference Citation Analysis]
406 Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, Vunnam SR. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. J Clin Virol. 2020;128:104386. [PMID: 32388469 DOI: 10.1016/j.jcv.2020.104386] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
407 Da BL, Kushner T, El Halabi M, Paka P, Khalid M, Uberoi A, Lee BT, Perumalswami PV, Rutledge SM, Schiano TD, Friedman S, Saberi B. Liver Injury in Hospitalized Patients with COVID-19 Correlates with Hyper Inflammatory Response and Elevated IL-6. Hepatol Commun. 2020;. [PMID: 33230491 DOI: 10.1002/hep4.1631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
408 Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M. Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic. Rev Gastroenterol Mex (Engl Ed) 2020;85:312-20. [PMID: 32620315 DOI: 10.1016/j.rgmx.2020.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Burwick RM, Yawetz S, Stephenson KE, Collier AY, Sen P, Blackburn BG, Kojic EM, Hirshberg A, Suarez JF, Sobieszczyk ME, Marks KM, Mazur S, Big C, Manuel O, Morlin G, Rose SJ, Naqvi M, Goldfarb IT, DeZure A, Telep L, Tan SK, Zhao Y, Hahambis T, Hindman J, Chokkalingam AP, Carter C, Das M, Osinusi AO, Brainard DM, Varughese TA, Kovalenko O, Sims MD, Desai S, Swamy G, Sheffield JS, Zash R, Short WR. Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19. Clin Infect Dis 2020:ciaa1466. [PMID: 33031500 DOI: 10.1093/cid/ciaa1466] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
410 Guarino M, Cossiga V, Fiorentino A, Pontillo G, Morisco F. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study. J Med Internet Res 2020;22:e20874. [PMID: 32896833 DOI: 10.2196/20874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
411 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
412 Chaibi S, Boussier J, Hajj WE, Abitbol Y, Taieb S, Horaist C, Jouannaud V, Wang P, Piquet J, Maurer C, Lahmek P, Nahon S. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort. Clin Res Hepatol Gastroenterol 2020;:101556. [PMID: 33139241 DOI: 10.1016/j.clinre.2020.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
413 Pickard A, Calverley BC, Chang J, Garva R, Gago S, Lu Y, Kadler KE. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells. PLoS Pathog 2021;17:e1009840. [PMID: 34499689 DOI: 10.1371/journal.ppat.1009840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Abdulrahman A, AlSayed I, AlMadhi M, AlArayed J, Mohammed SJ, Sharif AK, Alansari K, AlAwadhi AI, AlQahtani M. The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort. Infect Dis Ther 2021;10:439-55. [PMID: 33484407 DOI: 10.1007/s40121-021-00397-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M;  APASL COVID Task Force; APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
416 Snipelisky D, Johnson R, Prasad R, Lakhani B, Ellington J. Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2. South Med J 2020;113:618-22. [PMID: 33263129 DOI: 10.14423/SMJ.0000000000001182] [Reference Citation Analysis]
417 Gu X, Li X, An X, Yang S, Wu S, Yang X, Wang H. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay. J Clin Lab Anal. 2020;34:e23391. [PMID: 32488888 DOI: 10.1002/jcla.23391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
418 Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, Cunha L, Spearman CW, Sonderup MW, Kateera F. Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2020;5:634-636. [PMID: 32553140 DOI: 10.1016/s2468-1253(20)30155-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
419 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
420 de Vasconcelos Gaspar A, Santos Silva I. SARS-CoV-2 in Pregnancy-The First Wave. Medicina (Kaunas) 2021;57:241. [PMID: 33807607 DOI: 10.3390/medicina57030241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
422 Chen P, Zhou B. Clinical Characteristics of COVID-19 in Patients With Liver Injury. Clin Gastroenterol Hepatol. 2020;18:2846-2847. [PMID: 32407783 DOI: 10.1016/j.cgh.2020.04.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
423 Fierro NA. COVID-19 and the liver: What do we know after six months of the pandemic? Ann Hepatol 2020;19:590-1. [PMID: 32956871 DOI: 10.1016/j.aohep.2020.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
424 Pirola CJ, Sookoian S. COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism. Gastroenterology. 2020;159:1620-1621. [PMID: 32348773 DOI: 10.1053/j.gastro.2020.04.050] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
425 Marchandot B, Sattler L, Jesel L, Matsushita K, Schini-Kerth V, Grunebaum L, Morel O. COVID-19 Related Coagulopathy: A Distinct Entity? J Clin Med 2020;9:E1651. [PMID: 32486469 DOI: 10.3390/jcm9061651] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 25.5] [Reference Citation Analysis]
426 Saha P, Bose S, Srivastava AK, Chaudhary AA, Lall R, Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 2021;26:6783. [PMID: 34833873 DOI: 10.3390/molecules26226783] [Reference Citation Analysis]
427 Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Arab J Gastroenterol. 2020;21:3-8. [PMID: 32253172 DOI: 10.1016/j.ajg.2020.03.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 29.0] [Reference Citation Analysis]
428 Zhao JN, Fan Y, Wu SD. Liver injury in COVID-19: A minireview. World J Clin Cases 2020; 8(19): 4303-4310 [PMID: 33083389 DOI: 10.12998/wjcc.v8.i19.4303] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
429 Ashktorab H, Pizuomo A, González NAF, Villagrana EDC, Herrera-Solís ME, Cardenas G, Zavala-Alvarez D, Oskrochi G, Awoyemi E, Adeleye F, Dalivand MM, Laiyemo AO, Lee EE, Aduli F, Sherif ZA, Brim H. A Comprehensive Analysis of COVID-19 Impact in Latin America. Res Sq 2021:rs. [PMID: 33442675 DOI: 10.21203/rs.3.rs-141245/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
430 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
431 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
432 M Hussein A, Taha ZB, Gailan Malek A, Akram Rasul K, Hazim Kasim D, Jalal Ahmed R, Badraden Mohamed U. D-Dimer and Serum ferritin as an Independent Risk Factor for Severity in COVID-19 Patients. Mater Today Proc 2021. [PMID: 33868964 DOI: 10.1016/j.matpr.2021.04.009] [Reference Citation Analysis]
433 Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, Behr J, Capellier G, Soumagne T, Pili-Floury S, Besch G, Mourey G, Lepiller Q, Chirouze C, Schiele F, Chopard R, Meneveau N. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Eur Respir J 2020;56:2001811. [PMID: 32907890 DOI: 10.1183/13993003.01811-2020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
434 Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: The current evidence. United European Gastroenterol J. 2020;8:509-519. [PMID: 32450787 DOI: 10.1177/2050640620924157] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
435 Neumann NR, Chai PR, Wood DM, Greller HA, Mycyk MB. Medical Toxicology and COVID-19: Our Role in a Pandemic. J Med Toxicol 2020;16:245-7. [PMID: 32356251 DOI: 10.1007/s13181-020-00778-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
436 Takahashi T, Luzum JA, Nicol MR, Jacobson PA. Pharmacogenomics of COVID-19 therapies. NPJ Genom Med 2020;5:35. [PMID: 32864162 DOI: 10.1038/s41525-020-00143-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
437 Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
438 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Reference Citation Analysis]
439 Ahmed M. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. Gastroenterology Res 2020;13:89-95. [PMID: 32655724 DOI: 10.14740/gr1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
440 Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol 2020;8:18-24. [PMID: 32274342 DOI: 10.14218/JCTH.2020.00018] [Cited by in Crossref: 148] [Cited by in F6Publishing: 118] [Article Influence: 74.0] [Reference Citation Analysis]
441 Kushner T, Cafardi J. Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Clin Liver Dis (Hoboken). 2020;15:195-199. [PMID: 32537135 DOI: 10.1002/cld.974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
442 Lei M, Lin K, Pi Y, Huang X, Fan L, Huang J, Liu R, Liu L, Shao X, Hu K, Yang L, Qin S, He F. Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes. J Diabetes Res 2020;2020:5237840. [PMID: 33381599 DOI: 10.1155/2020/5237840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
443 Sabers AJ, Williams AL, Farley TM. Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection. BMJ Case Rep 2020;13:e239210. [PMID: 33130588 DOI: 10.1136/bcr-2020-239210] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
444 Bai Y, Huang W, Li Y, Lai C, Huang S, Wang G, He Y, Hu L, Chen C. Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry. Biosci Rep 2021;41:BSR20204305. [PMID: 33635316 DOI: 10.1042/BSR20204305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
445 Pegoraro F, Trapani S, Indolfi G. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children. Clin Res Hepatol Gastroenterol 2021;46:101818. [PMID: 34607068 DOI: 10.1016/j.clinre.2021.101818] [Reference Citation Analysis]
446 Calapod OP, Marin AM, Onisai M, Tribus LC, Pop CS, Fierbinteanu-Braticevici C. The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. Medicina (Kaunas) 2021;57:434. [PMID: 33946377 DOI: 10.3390/medicina57050434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
447 Hamed MA. An overview on COVID-19: reality and expectation. Bull Natl Res Cent 2020;44:86. [PMID: 32514228 DOI: 10.1186/s42269-020-00341-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
448 Saad MH, Badierah R, Redwan EM, El-Fakharany EM. A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions. Pharmaceutics 2021;13:1405. [PMID: 34575480 DOI: 10.3390/pharmaceutics13091405] [Reference Citation Analysis]
449 Sanz Segura P, Arguedas Lázaro Y, Mostacero Tapia S, Cabrera Chaves T, Sebastián Domingo JJ. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol 2020;43:464-71. [PMID: 32859408 DOI: 10.1016/j.gastrohep.2020.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
450 Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5:667-78. [PMID: 32405603 DOI: 10.1016/S2468-1253(20)30126-6] [Cited by in Crossref: 324] [Cited by in F6Publishing: 212] [Article Influence: 162.0] [Reference Citation Analysis]
451 Filippidis P, van Ouwenaller F, Cerutti A, Geiger-Jacquod A, Sempoux C, Pantaleo G, Moradpour D, Lamoth F. Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis. F1000Res 2021;10:400. [PMID: 34900226 DOI: 10.12688/f1000research.52929.2] [Reference Citation Analysis]
452 Benedicto A, García-Kamiruaga I, Arteta B. Neuropilin-1: A feasible link between liver pathologies and COVID-19. World J Gastroenterol 2021; 27(24): 3516-3529 [PMID: 34239266 DOI: 10.3748/wjg.v27.i24.3516] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Tan HW, Xu YM, Lau ATY. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Rev Med Virol 2020;30:e2122. [PMID: 32602627 DOI: 10.1002/rmv.2122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
454 Revzin MV, Raza S, Srivastava NC, Warshawsky R, D'Agostino C, Malhotra A, Bader AS, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations. Radiographics. 2020;40:1866-1892. [PMID: 33136488 DOI: 10.1148/rg.2020200195] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
455 Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol 2021;7:297-304. [PMID: 34712832 DOI: 10.5114/ceh.2021.109225] [Reference Citation Analysis]
456 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
457 Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far. World J Hepatol 2020; 12(12): 1182-1197 [PMID: 33442447 DOI: 10.4254/wjh.v12.i12.1182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
458 Kumar P, Sharma M, Kulkarni A, Rao PN. Pathogenesis of Liver Injury in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:641-642. [PMID: 32837092 DOI: 10.1016/j.jceh.2020.05.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
459 Choy KW. Urgent call to clinicians and researchers: 2020 acuity required when assessing and reporting laboratory abnormalities in COVID-19. Intern Med J 2020;50:892-3. [PMID: 32656976 DOI: 10.1111/imj.14883] [Reference Citation Analysis]
460 Calleri A, Saracco M, Pittaluga F, Cavallo R, Romagnoli R, Martini S. Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? Liver Transpl 2021. [PMID: 34564945 DOI: 10.1002/lt.26312] [Reference Citation Analysis]
461 Shen JX, Zhuang ZH, Zhang QX, Huang JF, Chen GP, Fang YY, Cheng AG. Risk Factors and Prognosis in Patients with COVID-19 and Liver Injury: A Retrospective Analysis. J Multidiscip Healthc 2021;14:629-37. [PMID: 33731999 DOI: 10.2147/JMDH.S293378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Adukia SA, Ruhatiya RS, Maheshwarappa HM, Manjunath RB, Jain GN. Extrapulmonary Features of COVID-19: A Concise Review. Indian J Crit Care Med 2020;24:575-80. [PMID: 32963443 DOI: 10.5005/jp-journals-10071-23476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
463 Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 2020;73:1063-71. [PMID: 32526252 DOI: 10.1016/j.jhep.2020.06.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 110] [Article Influence: 46.5] [Reference Citation Analysis]
464 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Reference Citation Analysis]
465 Zhang T, Huang WS, Guan W, Hong Z, Gao J, Gao G, Wu G, Qin YY. Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression. J Thorac Dis 2020;12:7429-41. [PMID: 33447431 DOI: 10.21037/jtd-20-1743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
466 Guo Q, Xu W, Wang PF, Ji HY, Zhang XL, Wang K, Li J. Facing coronavirus disease 2019: What do we know so far? (Review). Exp Ther Med 2021;21:658. [PMID: 33968188 DOI: 10.3892/etm.2021.10090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
467 Goneppanavar U, Desai S, Kaur J, Phatake RS, Sachidananda R, Bhat R. Practical approach for safe anesthesia in a COVID-19 patient scheduled for emergency laparotomy. J Anaesthesiol Clin Pharmacol 2020;36:S57-61. [PMID: 33100648 DOI: 10.4103/joacp.JOACP_230_20] [Reference Citation Analysis]
468 Lee KA, McBride RS, Narlawar R, Myers R, Antoniou GA. COVID Toes: Concurrent Lower Limb Arterial and Venous Thromboembolism in a Patient with COVID-19 Pneumonitis Presenting with Foot Ischaemia. Vasc Endovascular Surg 2021;:15385744211045600. [PMID: 34592855 DOI: 10.1177/15385744211045600] [Reference Citation Analysis]
469 Klocperk A, Bloomfield M, Parackova Z, Zentsova I, Vrabcova P, Balko J, Meseznikov G, Casas Mendez LF, Grandcourtova A, Sipek J, Tulach M, Zamecnik J, Vymazal T, Sediva A. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19. J Clin Med 2020;9:E3000. [PMID: 32957548 DOI: 10.3390/jcm9093000] [Reference Citation Analysis]
470 Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology 2020:S2531-0437(20)30254-3. [PMID: 33358260 DOI: 10.1016/j.pulmoe.2020.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
471 Jiang B, Liang S, Liang G, Wei H. Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis? Eur Rev Med Pharmacol Sci 2020;24:10228-38. [PMID: 33090434 DOI: 10.26355/eurrev_202010_23247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
472 [DOI: 10.1101/2020.06.04.20122457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
474 Annunziata A, Coppola A, Andreozzi P, Lanza M, Simioli F, Carannante N, Di Somma C, Di Micco P, Fiorentino G. Acute Pancreatitis and COVID-19: A Single-Center Experience. J Multidiscip Healthc 2021;14:2857-61. [PMID: 34675533 DOI: 10.2147/JMDH.S334835] [Reference Citation Analysis]
475 Kirkham AM, Monaghan M, Bailey AJM, Shorr R, Lalu MM, Fergusson DA, Allan DS. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol. Syst Rev 2021;10:249. [PMID: 34526123 DOI: 10.1186/s13643-021-01803-5] [Reference Citation Analysis]
476 Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: Its impact on liver disease and liver transplantation. World J Gastroenterol 2020; 26(22): 2987-2999 [PMID: 32587443 DOI: 10.3748/wjg.v26.i22.2987] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
477 Pessoa NL, Bentes AA, de Carvalho AL, de Souza Silva TB, Alves PA, de Sousa Reis EV, Rodrigues TA, Kroon EG, Campos MA. Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism. Virol J 2021;18:180. [PMID: 34482844 DOI: 10.1186/s12985-021-01656-3] [Reference Citation Analysis]
478 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
479 Soto ME, Guarner-Lans V, Soria-Castro E, Manzano Pech L, Pérez-Torres I. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application. Medicina (Kaunas) 2020;56:E386. [PMID: 32752010 DOI: 10.3390/medicina56080386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
480 Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020;51:613-628. [PMID: 33011887 DOI: 10.1007/s10735-020-09915-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 30.5] [Reference Citation Analysis]
481 Haitao T, Vermunt JV, Abeykoon J, Ghamrawi R, Gunaratne M, Jayachandran M, Narang K, Parashuram S, Suvakov S, Garovic VD. COVID-19 and Sex Differences: Mechanisms and Biomarkers. Mayo Clin Proc 2020;95:2189-203. [PMID: 33012349 DOI: 10.1016/j.mayocp.2020.07.024] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 23.5] [Reference Citation Analysis]
482 Shoaib MH, Ahmed FR, Sikandar M, Yousuf RI, Saleem MT. A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. Front Pharmacol 2021;12:576448. [PMID: 33732150 DOI: 10.3389/fphar.2021.576448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Wang M, Fan Y, Chai Y, Cheng W, Wang K, Cao J, Hu X. Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China. Front Cell Infect Microbiol 2021;11:667487. [PMID: 34123873 DOI: 10.3389/fcimb.2021.667487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
484 Fraga M, Moradpour D, Artru F, Romailler E, Tschopp J, Schneider A, Chtioui H, Neerman-Arbez M, Casini A, Alberio L, Sempoux C. Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis. J Hepatol 2020;73:967-70. [PMID: 32585161 DOI: 10.1016/j.jhep.2020.06.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
485 Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793 [PMID: 33727770 DOI: 10.3748/wjg.v27.i9.782] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
486 Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol 2020; 26(19): 2286-2293 [PMID: 32476793 DOI: 10.3748/wjg.v26.i19.2286] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 29] [Article Influence: 20.0] [Reference Citation Analysis]
487 Jia W, Wang J, Sun B, Zhou J, Shi Y, Zhou Z. The Mechanisms and Animal Models of SARS-CoV-2 Infection. Front Cell Dev Biol 2021;9:578825. [PMID: 33987176 DOI: 10.3389/fcell.2021.578825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
488 Luo K, Chen Y, Yang J, Tao Q, Luo M. Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19. Front Public Health 2021;9:778340. [PMID: 34970527 DOI: 10.3389/fpubh.2021.778340] [Reference Citation Analysis]
489 Anness A, Siddiqui F. COVID-19 complicated by hepatic dysfunction in a 28-week pregnant woman. BMJ Case Rep 2020;13:e237007. [PMID: 32878840 DOI: 10.1136/bcr-2020-237007] [Reference Citation Analysis]
490 Hu Y, Zuo M, Wang X, Wang R, Li L, Lu X, Jiang S. Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats. J Zhejiang Univ Sci B 2021;22:599-602. [PMID: 34269012 DOI: 10.1631/jzus.B2000728] [Reference Citation Analysis]
491 Cîrstea AE, Buzulică RL, Pirici D, Ceauşu MC, Iman RV, Gheorghe OM, Neamţu SD, Stanca L, Ene R, Kumar-Singh S, Mogoantă L. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection. Rom J Morphol Embryol 2020;61:209-18. [PMID: 32747912 DOI: 10.47162/RJME.61.1.23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
492 Choudhary A, Singh V, Bharadwaj M, Barik A. Pregnancy With SARS-CoV-2 Infection Complicated by Preeclampsia and Acute Fatty Liver of Pregnancy. Cureus 2021;13:e15645. [PMID: 34306855 DOI: 10.7759/cureus.15645] [Reference Citation Analysis]
493 Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;54:949-59. [PMID: 32475821 DOI: 10.1136/bjsports-2020-102596] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 50.5] [Reference Citation Analysis]
494 Nkeih C, Sisti G, Schiattarella A. Elevated transaminases in a COVID-19 positive patient at term of gestation: a case report. Acta Biomed 2020;91:e2020002. [PMID: 32921751 DOI: 10.23750/abm.v91i3.9796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
495 Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Gastroenterol Hepatol 2020;43:472-80. [PMID: 32727662 DOI: 10.1016/j.gastrohep.2020.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
496 Ellison-Hughes GM, Colley L, O'Brien KA, Roberts KA, Agbaedeng TA, Ross MD. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.Front Cardiovasc Med. 2020;7:602183. [PMID: 33363221 DOI: 10.3389/fcvm.2020.602183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
497 Borges do Nascimento IJ, von Groote TC, O'Mathúna DP, Abdulazeem HM, Henderson C, Jayarajah U, Weerasekara I, Poklepovic Pericic T, Klapproth HEG, Puljak L, Cacic N, Zakarija-Grkovic I, Guimarães SMM, Atallah AN, Bragazzi NL, Marcolino MS, Marusic A, Jeroncic A; International Task Force Network of Coronavirus Disease 2019 (InterNetCOVID-19). Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses. PLoS One 2020;15:e0239235. [PMID: 32941548 DOI: 10.1371/journal.pone.0239235] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
498 Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2950-73. [PMID: 32311448 DOI: 10.1016/j.jacc.2020.04.031] [Cited by in Crossref: 1202] [Cited by in F6Publishing: 1150] [Article Influence: 601.0] [Reference Citation Analysis]
499 Silva FAFD, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, de Sousa Cruz S, Rocha GR, Correa Santos GL, de Souza KC, Maciel RGA, Lopes DS, Silva NOE, Oliveira MV, de Melo FF. Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. World J Clin Cases 2021; 9(28): 8280-8294 [PMID: 34754839 DOI: 10.12998/wjcc.v9.i28.8280] [Reference Citation Analysis]
500 Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol. 2021;74:76-83. [PMID: 32817204 DOI: 10.1136/jclinpath-2020-206995] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
501 Mansoor E, Perez A, Abou-Saleh M, Sclair SN, Cohen S, Cooper GS, Mills A, Schlick K, Khan A. Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study. Gastroenterology 2021;160:459-462.e1. [PMID: 33010251 DOI: 10.1053/j.gastro.2020.09.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
502 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
503 Costa LB, Perez LG, Palmeira VA, Macedo E Cordeiro T, Ribeiro VT, Lanza K, Simões E Silva AC. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Front Cell Dev Biol 2020;8:559841. [PMID: 33042994 DOI: 10.3389/fcell.2020.559841] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
504 Wiśniewska H, Skowron M, Bander D, Hornung M, Jurczyk K, Karpińska E, Laurans Ł, Socha Ł, Czajkowski Z, Wawrzynowicz-Syczewska M. Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report. Am J Case Rep 2020;21:e927452. [PMID: 32973125 DOI: 10.12659/AJCR.927452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
505 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
506 Kaiser FK, Wiens M, Schultmann F. Use of digital healthcare solutions for care delivery during a pandemic-chances and (cyber) risks referring to the example of the COVID-19 pandemic. Health Technol (Berl) 2021;:1-13. [PMID: 33875933 DOI: 10.1007/s12553-021-00541-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
507 Gomi K, Ito T, Yamaguchi F, Kamio Y, Sato Y, Mori H, Endo K, Abe T, Sakakura S, Kobayashi K, Shimada K, Noda J, Hibiki T, Ohta S, Sagara H, Tanaka A, Jinno M, Yamawaki M, Nishimoto F, Inoue K, Nagahama M. Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019. JGH Open 2021;5:888-95. [PMID: 34386596 DOI: 10.1002/jgh3.12599] [Reference Citation Analysis]
508 Ji F, Wang L, Li C, Wang L, Hao J, Dai M, Liu Y, Pan X, Fu J, Li L, Yang G, Yang J, Zhang X, Wang J, Wang R, Yan X, Gu B. Clinical findings in a group of COVID-19 patients: a single-center retrospective study. Ann Transl Med 2021;9:44. [PMID: 33553337 DOI: 10.21037/atm-20-3333] [Reference Citation Analysis]
509 Cao P, Wu Y, Wu S, Wu T, Zhang Q, Zhang R, Wang Z, Zhang Y. Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia. Biomarkers. 2021;26:207-212. [PMID: 33284041 DOI: 10.1080/1354750x.2020.1861098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
510 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
511 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020;. [PMID: 32950749 DOI: 10.1016/j.cgh.2020.09.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
512 Zhou Y, Ding F, Bao W, Xue Y, Han L, Zhang X, Zhang P, Ji Y, Yin D, Bao A, Luo S, Xu Z, Liu J, Zhang M. Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. Ann Transl Med 2021;9:665. [PMID: 33987363 DOI: 10.21037/atm-21-445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
513 Strafella C, Caputo V, Termine A, Barati S, Caltagirone C, Giardina E, Cascella R. Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders. Life (Basel) 2020;10:E351. [PMID: 33339153 DOI: 10.3390/life10120351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
514 Highton AJ, Schuster IS, Degli-Esposti MA, Altfeld M. The role of natural killer cells in liver inflammation. Semin Immunopathol 2021. [PMID: 34230995 DOI: 10.1007/s00281-021-00877-6] [Reference Citation Analysis]
515 Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 2020;56:106024. [PMID: 32450197 DOI: 10.1016/j.ijantimicag.2020.106024] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 44.0] [Reference Citation Analysis]
516 Zolfaghari Emameh R, Falak R, Bahreini E. Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2. Biol Proced Online 2020;22:11. [PMID: 32572334 DOI: 10.1186/s12575-020-00124-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
517 Simonis A, Theobald SJ, Fätkenheuer G, Rybniker J, Malin JJ. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2. EMBO Mol Med 2021;13:e13105. [PMID: 33015938 DOI: 10.15252/emmm.202013105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
518 Shou S, Liu M, Yang Y, Kang N, Song Y, Tan D, Liu N, Wang F, Liu J, Xie Y. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates. Front Microbiol 2021;12:626553. [PMID: 34531831 DOI: 10.3389/fmicb.2021.626553] [Reference Citation Analysis]
519 Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin. Saudi J Gastroenterol 2020;26:272-8. [PMID: 32769260 DOI: 10.4103/sjg.SJG_239_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
520 Zhang SS, Dong L, Wang GM, Tian Y, Ye XF, Zhao Y, Liu ZY, Zhai JY, Zhao ZL, Wang JH, Zhang HM, Li XL, Wu CX, Yang CT, Yang LJ, Du HX, Wang H, Ge QG, Xiu DR, Shen N. Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China. World J Gastroenterol 2021; 27(9): 835-853 [PMID: 33727773 DOI: 10.3748/wjg.v27.i9.835] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
521 Esposito S, Gnocchi M, Gagliardi M, Affanni P, Veronesi L, Colucci ME, Neglia C, Argentiero A, Principi N. Therapeutic strategies against COVID-19. Acta Biomed 2020;91:e2020038. [PMID: 32921732 DOI: 10.23750/abm.v91i3.10450] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
522 Fenrich M, Mrdenovic S, Balog M, Tomic S, Zjalic M, Roncevic A, Mandic D, Debeljak Z, Heffer M. SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury. Front Cell Neurosci 2020;14:229. [PMID: 32848621 DOI: 10.3389/fncel.2020.00229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
523 Alnafiey MO, Alangari AM, Alarifi AM, Abushara A. Persistent Hypokalemia post SARS-coV-2 infection, is it a life-long complication? Case report. Ann Med Surg (Lond) 2021;62:358-61. [PMID: 33527042 DOI: 10.1016/j.amsu.2021.01.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
524 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
525 Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol. 2021;56:218-230. [PMID: 33527211 DOI: 10.1007/s00535-021-01760-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
526 Almas T, Ehtesham M, Khedro T, Haadi A, Nabeel AR, Hussain S, Alsufyani R, Al-Awaid AH, Sclair S, Mansoor E. The many faces of coronavirus disease 2019: COVID-19 and the liver. Ann Med Surg (Lond) 2021;64:102224. [PMID: 33747505 DOI: 10.1016/j.amsu.2021.102224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
527 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
528 Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic. Singapore Med J 2020;61:619-23. [PMID: 32349198 DOI: 10.11622/smedj.2020069] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
529 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Reference Citation Analysis]
530 Suresh Kumar VC, Harne PS, Mukherjee S, Gupta K, Masood U, Sharma AV, Lamichhane J, Dhamoon AS, Sapkota B. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12(9): 619-627 [PMID: 33033568 DOI: 10.4254/wjh.v12.i9.619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Kang MK, Kim KO, Kim MC, Cho JH, Kim SB, Park JG, Kim KH, Lee SH, Jang BI, Kim TN. Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu. Korean J Intern Med 2020;35:1261-9. [PMID: 32872734 DOI: 10.3904/kjim.2020.196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
532 FitzGerald ES, Jamieson AM. Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies. bioRxiv 2020:2020. [PMID: 32676594 DOI: 10.1101/2020.07.06.182972] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
533 Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB;  AGA Institute. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020;159:320-334.e27. [PMID: 32407808 DOI: 10.1053/j.gastro.2020.05.001] [Cited by in Crossref: 145] [Cited by in F6Publishing: 143] [Article Influence: 72.5] [Reference Citation Analysis]
534 Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, Wu KC, Chen MH; Chinese Society of IBD, Chinese Elite IBD Union., Chinese IBD Quality Care Evaluation Center Committee. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol 2020;5:425-7. [PMID: 32171057 DOI: 10.1016/S2468-1253(20)30076-5] [Cited by in Crossref: 181] [Cited by in F6Publishing: 130] [Article Influence: 90.5] [Reference Citation Analysis]
535 Singhai A, Pavan GS, Panda S. Evaluation of liver function in symptomatic COVID-19 patients. J Family Med Prim Care 2021;10:3252-6. [PMID: 34760739 DOI: 10.4103/jfmpc.jfmpc_2527_20] [Reference Citation Analysis]
536 Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N, Viazis N, Liatsos C, Mantzaris GJ. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol 2020; 26(31): 4579-4588 [PMID: 32884218 DOI: 10.3748/wjg.v26.i31.4579] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
537 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
538 Wang S, Chen Z, Lin Y, Lin L, Lin Q, Fang S, Shi Y, Zhuang X, Ye Y, Wang T, Zhang H, Shao C. Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: A multicenter retrospective study between January 22nd and February 27th, 2020. PLoS One 2020;15:e0242307. [PMID: 33180862 DOI: 10.1371/journal.pone.0242307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
539 Liu F, Cai ZB, Huang JS, Yu WY, Niu HY, Zhang Y, Sui DM, Wang F, Xue LZ, Xu AF. Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up. Pathog Dis 2020;78:ftaa031. [PMID: 32592396 DOI: 10.1093/femspd/ftaa031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
540 Malik P, Patel K, Akrmah M, Donthi D, Patel U, Khader SN, Asiry S. COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS. SN Compr Clin Med 2021;:1-28. [PMID: 34396046 DOI: 10.1007/s42399-021-01029-5] [Reference Citation Analysis]
541 Medetalibeyoglu A, Catma Y, Senkal N, Ormeci A, Cavus B, Kose M, Bayramlar OF, Yildiz G, Akyuz F, Kaymakoglu S, Tukek T. The effect of liver test abnormalities on the prognosis of COVID-19. Ann Hepatol 2020;19:614-21. [PMID: 32920162 DOI: 10.1016/j.aohep.2020.08.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
542 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
543 Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas) 2021;57:1057. [PMID: 34684094 DOI: 10.3390/medicina57101057] [Reference Citation Analysis]
544 Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, Wang FS. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun 2020;112:102473. [PMID: 32439209 DOI: 10.1016/j.jaut.2020.102473] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 44.5] [Reference Citation Analysis]
545 Vallamkondu J, John A, Wani WY, Ramadevi SP, Jella KK, Reddy PH, Kandimalla R. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets. Biochim Biophys Acta Mol Basis Dis 2020;1866:165889. [PMID: 32603829 DOI: 10.1016/j.bbadis.2020.165889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
546 Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci 2020;10:E852. [PMID: 33198412 DOI: 10.3390/brainsci10110852] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
547 Widjaja G, Turki Jalil A, Sulaiman Rahman H, Kamal Abdelbasset W, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19. Hum Immunol 2021:S0198-8859(21)00174-9. [PMID: 34229864 DOI: 10.1016/j.humimm.2021.06.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Aguila EJT, Cua IHY, Dumagpi JEL, Francisco CPD, Raymundo NTV, Sy-Janairo MLL, Cabral-Prodigalidad PAI, Lontok MAD. COVID-19 and its effects on the digestive system and endoscopy practice. JGH Open. 2020;4:324-331. [PMID: 32514432 DOI: 10.1002/jgh3.12358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
549 Kantri A, Ziati J, Khalis M, Haoudar A, El Aidaoui K, Daoudi Y, Chikhaoui I, El Yamani K, Mouhaoui M, El Bakkouri J, Dini N, Mahi M, Naitlho A, Bahlaoui A, Bennana A, Noussair M, Belyamani L, El Kettani C. Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco. PLoS One 2021;16:e0246295. [PMID: 33539383 DOI: 10.1371/journal.pone.0246295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
550 Zong X, Gu Y, Yu H, Li Z, Wang Y. Thrombocytopenia Is Associated with COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients with Multiple Outcomes. Lab Med 2021;52:10-5. [PMID: 32929506 DOI: 10.1093/labmed/lmaa067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
551 Kheir M, Saleem F, Wang C, Mann A, Chua J. Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. PLoS One 2021;16:e0248358. [PMID: 33725003 DOI: 10.1371/journal.pone.0248358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
552 Luglio M, Tannuri U, de Carvalho WB, Bastos KLM, Rodriguez IS, Johnston C, Delgado AF. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics (Sao Paulo) 2020;75:e2250. [PMID: 33206767 DOI: 10.6061/clinics/2020/e2250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
553 Zhang D, Zhu Z, Bi J, Feng D, Zhang L, Liu H, Gao Y. Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury. Med Sci Monit 2020;26:e928849. [PMID: 33339813 DOI: 10.12659/MSM.928849] [Reference Citation Analysis]
554 Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, Stamatelopoulos K, Terpos E, Kotanidou A, Hagberg CA, Dimopoulos MA, Kontoyiannis DP. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J Infect 2021;83:1-16. [PMID: 33992686 DOI: 10.1016/j.jinf.2021.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
555 Ghayda RA, Lee J, Lee JY, Kim DK, Lee KH, Hong SH, Han YJ, Kim JS, Yang JW, Kronbichler A, Smith L, Koyanagi A, Jacob L, Shin JI. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2020;17:E5026. [PMID: 32668763 DOI: 10.3390/ijerph17145026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
556 Abu Jawdeh BG. COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges. Adv Chronic Kidney Dis 2020;27:383-9. [PMID: 33308503 DOI: 10.1053/j.ackd.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
557 Ferrara F, De Rosa F, Vitiello A. Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? SN Compr Clin Med 2020;:1-2. [PMID: 32838149 DOI: 10.1007/s42399-020-00375-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
558 Lim MA, Pranata R, Huang I, Yonas E, Soeroto AY, Supriyadi R. Multiorgan Failure With Emphasis on Acute Kidney Injury and Severity of COVID-19: Systematic Review and Meta-Analysis. Can J Kidney Health Dis 2020;7:2054358120938573. [PMID: 32685180 DOI: 10.1177/2054358120938573] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
559 Zhai C, Wang M, Chung HJ, Hassan M, Lee S, Kim HJ, Hong ST. Roborovski hamster (Phodopus roborovskii) strain SH101 as a systemic infection model of SARS-CoV-2. Virulence 2021;12:2430-42. [PMID: 34517779 DOI: 10.1080/21505594.2021.1972201] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 Saini RK, Saini N, Ram S, Soni SL, Suri V, Malhotra P, Kaur J, Verma I, Sharma S, Zohmangaihi D. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2020;. [PMID: 33184141 DOI: 10.1136/postgradmedj-2020-138930] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
561 Qi X, Liu Y, Wang J, Fallowfield JA, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC;  COVID-Cirrhosis-CHESS Group. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Gut. 2021;70:433-436. [PMID: 32434831 DOI: 10.1136/gutjnl-2020-321666] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
562 Baghchechi M, Jaipaul N, Jacob SE. The rise and evolution of COVID-19. Int J Womens Dermatol 2020;6:248-54. [PMID: 32838013 DOI: 10.1016/j.ijwd.2020.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
563 Chen H, Li X, Marmar T, Xu Q, Tu J, Li T, Han J, Xu D, Shen T. Cardiac Troponin I association with critical illness and death risk in 726 seriously ill COVID-19 patients: A retrospective cohort study. Int J Med Sci 2021;18:1474-83. [PMID: 33628105 DOI: 10.7150/ijms.53641] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
564 Roca-Fernández A, Dennis A, Nicholls R, McGonigle J, Kelly M, Banerjee R, Banerjee A, Sanyal AJ. Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19. Front Med (Lausanne) 2021;8:636637. [PMID: 33855033 DOI: 10.3389/fmed.2021.636637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
565 Mousaad Elemam N, Hannawi H, Bin Naeem K, Hannawi S. A single centered study reveals association between liver injury and COVID-19 infection. Saudi J Biol Sci 2021. [PMID: 34220212 DOI: 10.1016/j.sjbs.2021.06.064] [Reference Citation Analysis]
566 Ballout RA, Kong H, Sampson M, Otvos JD, Cox AL, Agbor-Enoh S, Remaley AT. The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19. Biomedicines 2021;9:1090. [PMID: 34572275 DOI: 10.3390/biomedicines9091090] [Reference Citation Analysis]
567 Scarpellini E, Fagoonee S, Rinninella E, Rasetti C, Aquila I, Larussa T, Ricci P, Luzza F, Abenavoli L. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. J Clin Med 2020;9:E2488. [PMID: 32756323 DOI: 10.3390/jcm9082488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
568 Zhai G, Li M, Wang Y, Wu J. Drug-Induced Liver Disturbance During the Treatment of COVID-19. Front Pharmacol 2021;12:719308. [PMID: 34483929 DOI: 10.3389/fphar.2021.719308] [Reference Citation Analysis]
569 Xu L, Yu DD, Ma YH, Yao YL, Luo RH, Feng XL, Cai HR, Han JB, Wang XH, Li MH, Ke CW, Zheng YT, Yao YG. COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2. Zool Res 2020;41:517-26. [PMID: 32701249 DOI: 10.24272/j.issn.2095-8137.2020.053] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
570 Giovinazzo F, Avolio AW, Galiandro F, Vitale A, Dalla Riva GV, Biancofiore G, Sharma S, Muiesan P, Agnes S, Burra P. Solid Organ Transplantation During COVID-19 Pandemic: An International Web-based Survey on Resources' Allocation. Transplant Direct 2021;7:e669. [PMID: 34113712 DOI: 10.1097/TXD.0000000000001115] [Reference Citation Analysis]
571 Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front Physiol 2021;12:665064. [PMID: 34012410 DOI: 10.3389/fphys.2021.665064] [Reference Citation Analysis]
572 Li T, Sun L, Zhang W, Zheng C, Jiang C, Chen M, Chen D, Dai Z, Bao S, Shen X. Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study. Clin Transl Sci 2020;13:1096-102. [PMID: 32881359 DOI: 10.1111/cts.12881] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
573 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
574 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
575 Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20:493-506. [PMID: 32720223 DOI: 10.1007/s10238-020-00648-x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 52.5] [Reference Citation Analysis]
576 Goh KL, Chuah KH. COVID-19 and the digestive system: More than just a "flu". JGH Open. 2020;4:318-319. [PMID: 32514430 DOI: 10.1002/jgh3.12364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
577 Higuera-de-la-Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Rosales-Salyano VH, Casillas-Suárez C, Chapa-Azuela O, Chávez-Morales A, Jiménez-Bobadilla B, Hernández-Medel ML, Orozco-Zúñiga B, Zacarías-Ezzat JR, Camacho S, Pérez-Hernández JL. The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease. Dis Markers 2021;2021:6658270. [PMID: 33791045 DOI: 10.1155/2021/6658270] [Reference Citation Analysis]
578 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Reference Citation Analysis]
579 Akerele IO, Nnabuchi CV, Oreh AC. Coronavirus disease (COVID-19) and acute nonicteric hepatitis: A case report from Asokoro, Nigeria. J Family Community Med 2021;28:59-62. [PMID: 33679191 DOI: 10.4103/jfcm.JFCM_410_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
580 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
581 Bayram M, Yildirim O, Ozmen RS, Soylu B, Dundar AS, Koksal AR, Akarsu M, Kumbasar A, Tabak O. Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19. Cureus 2021;13:e18166. [PMID: 34703696 DOI: 10.7759/cureus.18166] [Reference Citation Analysis]
582 Yu C, Zhou M, Liu Y, Guo T, Ou C, Yang L, Li Y, Li D, Hu X, Shuai L, Wang B, Zou Z. Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study. Virulence 2020;11:1006-14. [PMID: 32722990 DOI: 10.1080/21505594.2020.1802194] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
583 Zheng QN, Xu MY, Zheng YL, Wang XY, Zhao H. Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19. Disaster Med Public Health Prep 2020;14:652-7. [PMID: 32576328 DOI: 10.1017/dmp.2020.214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P. Is liver involvement overestimated in COVID-19 patients? Int J Med Sci. 2021;18:1285-1296. [PMID: 33526990 DOI: 10.7150/ijms.51174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
585 Zuo G, Liu W. The clinical characteristics and underlying causes of liver damage in patients with COVID-19 infection: Retrospective analysis. Pak J Med Sci 2021;37:1282-7. [PMID: 34475899 DOI: 10.12669/pjms.37.5.4161] [Reference Citation Analysis]
586 Yigit Y, Haddad M, Elmoheen A, Shogaa MR, Tawel R, Mohamed YK, Salem W, Fawzy Eltawagny M. Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B. Case Rep Infect Dis 2021;2021:8818678. [PMID: 33564481 DOI: 10.1155/2021/8818678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
587 An YW, Yuan B, Wang JC, Wang C, Liu TT, Song S, Liu HQ. Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19. Int J Med Sci. 2021;18:646-651. [PMID: 33437199 DOI: 10.7150/ijms.52664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
588 Carotti M, Salaffi F, Sarzi-Puttini P, Agostini A, Borgheresi A, Minorati D, Galli M, Marotto D, Giovagnoni A. Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists. Radiol Med. 2020;125:636-646. [PMID: 32500509 DOI: 10.1007/s11547-020-01237-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 29.5] [Reference Citation Analysis]
589 Makar M, John Pisano T, Minacapelli CD, Rustgi V. Gastrointestinal Findings in a Patient With COVID-19. ACG Case Rep J 2020;7:e00392. [PMID: 32637437 DOI: 10.14309/crj.0000000000000392] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
590 Kunutsor SK, Laukkanen JA. Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis. J Infect 2020;81:e72-4. [PMID: 32579984 DOI: 10.1016/j.jinf.2020.06.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
591 Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F, Brown Jr RS, Carr-Locke D, Cohen DE, Sharaiha RZ. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020; 26(14): 1546-1553 [PMID: 32327904 DOI: 10.3748/wjg.v26.i14.1546] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
592 Yaneske E, Zampieri G, Bertoldi L, Benvenuto G, Angione C. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production. FEBS Lett 2021;595:2350-65. [PMID: 34409594 DOI: 10.1002/1873-3468.14180] [Reference Citation Analysis]
593 Barman HA, Pala AS, Dogan O, Atıcı A, Yumuk MT, Alici G, Sit O, Gungor B, Dogan SM. Prognostic significance of temporal changes of lipid profile in COVID-19 patients. Obes Med 2021;28:100373. [PMID: 34671707 DOI: 10.1016/j.obmed.2021.100373] [Reference Citation Analysis]
594 Sepehrinezhad A, Shahbazi A, Negah SS. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. J Neurovirol 2020;26:324-9. [PMID: 32418055 DOI: 10.1007/s13365-020-00851-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 11.5] [Reference Citation Analysis]
595 Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:533-539. [PMID: 32837096 DOI: 10.1016/j.jceh.2020.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
596 Çınar OE, Sayınalp B, Aladağ Karakulak E, Avşar Karataş A, Velet M, İnkaya AÇ, Ersoy Ortaç NE, Öcal S, Aksu S, Haznedaroğlu İC, Sayınalp N, Özcebe Oİ. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis. Transfus Apher Sci 2020;59:102821. [PMID: 32487513 DOI: 10.1016/j.transci.2020.102821] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
597 Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B. COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications. J Alzheimers Dis 2020;77:459-504. [PMID: 32925078 DOI: 10.3233/JAD-200831] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 12.5] [Reference Citation Analysis]
598 Verma V, Vishwakarma RK, Verma A, Nath DC, Khan HTA. Time-to-Death approach in revealing Chronicity and Severity of COVID-19 across the World. PLoS One 2020;15:e0233074. [PMID: 32396542 DOI: 10.1371/journal.pone.0233074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
599 He Y, Bai X, Zhu T, Huang J, Zhang H. What can the neurological manifestations of COVID-19 tell us: a meta-analysis. J Transl Med 2021;19:363. [PMID: 34425827 DOI: 10.1186/s12967-021-03039-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
600 Ganne-Carrié N, Fontaine H, Dumortier J, Boursier J, Bureau C, Leroy V, Bourlière M; AFEF, French Association for the Study of the Liver. Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic. Clin Res Hepatol Gastroenterol 2020;44:275-81. [PMID: 32360055 DOI: 10.1016/j.clinre.2020.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
601 Liu X, Wu Y, Rong L. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses. Virol Sin 2020;35:280-9. [PMID: 32557270 DOI: 10.1007/s12250-020-00244-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
602 Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol 2021;12:593223. [PMID: 33584343 DOI: 10.3389/fphys.2021.593223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]